phenoxi
heptyl
inhibit
replic
sever
picornavirus
otto
et
al
antimicrob
ag
chemoth
measur
viral
rna
synthesi
electron
microscopi
show
disoxaril
inhibit
replic
polioviru
type
hela
cell
prior
uncoat
stabil
viru
capsid
arriv
viral
rna
new
rna
synthesi
inhibit
complet
inocula
preincub
disoxaril
min
ilg
disoxarillml
polioviru
type
ug
disoxarillml
polioviru
type
simultan
addit
compound
viru
result
reduc
inhibit
viral
rna
synthesi
inhibitori
effect
compound
could
partial
revers
min
pi
compound
elut
cell
disoxaril
pretreat
polioviru
inhibit
enter
hela
cell
entri
receptormedi
endocytosi
via
coat
pit
vesicl
endosom
stimul
vitro
viru
particl
igg
produc
hybridoma
produc
antibodi
neutral
homolog
viru
antibodi
react
type
mahoney
recogn
lsc
sabin
strain
type
neutral
bind
viru
immunoprecipit
inhibit
preincub
antibodi
synthet
peptid
repres
amino
acid
sequenc
polioviru
type
mahoney
highli
specif
antibodi
therefor
recogn
neutral
epitop
locat
amino
acid
neutral
antibodi
polioviru
type
mahoney
rabbit
mice
use
synthet
peptid
sequenc
vp
wetz
k
ulrik
gravenhorstmunt
heinrichpett
inst
f
exp
virologi
u
immunologi
univ
hamburg
peptid
correspond
sequenc
immunodomin
polioviru
type
mahoney
synthes
two
addit
cystein
end
peptid
rigid
conform
peptid
format
close
circl
induc
homogen
antibodi
peptid
link
carrier
protein
keyhol
limpet
hemocyanin
klh
bovin
serum
albumin
bsa
glutardialdehyd
emulsifi
freund
adjuvan
ii
freshli
precipit
aluminiumhydroxid
aloxid
iii
monophosphoryl
lipida
contain
trehalos
dimicholat
ra
mice
rabbit
inject
five
time
subcutan
everi
ten
day
anim
produc
antibodi
bind
peptid
enzymelink
immunosorb
assay
elisa
also
bound
viru
moder
titer
compar
antiserum
viru
three
five
rabbit
antisera
neutral
viru
serum
dilut
two
mice
sera
respect
tcid
induct
coxsacki
b
specif
human
lymphocyt
line
use
tool
diagnos
whcih
viru
type
individu
reactiv
sklenar
k
bienz
p
erb
w
berger
inst
f
mikrobiologi
u
hygien
depart
f
inner
medizin
univ
basel
coxsacki
b
cb
virus
gain
increas
attent
multipot
pathogen
caus
eg
bornholm
diseas
asept
mening
myocard
possibl
type
diabet
case
virusspecif
igmelisatechniqu
often
use
diagnosi
howev
frequent
crossreact
antibodi
two
viru
type
found
work
comparison
cellular
immun
respons
humor
immun
gradient
purifi
cbvirus
perform
three
individu
crossreact
cb
cb
igg
antibodi
found
use
elisa
howev
lymphocyt
prolifer
predominantli
one
viru
type
addit
studi
tcell
line
okt
one
individu
reveal
stimul
one
viru
type
led
induct
tcell
specif
viru
type
use
cb
viru
imposs
induc
typespecif
tcell
line
data
suggest
tcell
memori
test
vitro
may
specif
test
antibodi
elisa
herrler
g
hd
klenk
inst
f
virologi
justusliebiguniv
gielsen
inst
f
virologi
philippsuniv
marburg
acid
shown
highaffin
receptor
determin
attach
influenzaa
c
viru
erythrocyt
present
evid
primari
receptor
determin
requir
influenza
c
viru
order
attach
tissu
cultur
cell
initi
infect
bovin
brain
gangliosid
contain
type
sialic
acid
found
potenti
receptor
influenza
c
viru
sever
cell
line
resist
infect
viru
becom
suscept
incub
bovin
brain
gangliosid
prior
infect
result
indic
lack
appropri
receptor
cell
surfac
major
reason
restrict
cell
tropism
influenza
c
viru
durkop
hd
klenk
g
herrler
inst
f
virologi
inst
f
virologi
philippsuniv
marburg
isol
fifteen
hybridoma
secret
monoclon
antibodi
direct
surfac
glycoprotein
gp
influenza
c
viru
antibodi
analyz
abil
inhibit
hemagglutin
acetylesteras
hemolyt
activ
influenza
c
viru
result
obtain
indic
surfac
glycoprotein
influenza
c
viru
addit
fusion
activ
also
hemagglutin
acetylesteras
activ
kuroda
l
k
c
hauser
r
groner
r
rott
w
doerfler
univ
gieben
gieben
univ
koln
hoechst
ag
univ
marburg
cdna
sequenc
fvp
hemagglutinin
gene
insert
bamhi
site
polyhedrin
vector
recombin
viru
obtain
cotransfect
construct
authent
acnpv
dna
hemagglutinin
gene
locat
polyhedrin
gene
recombin
viru
genom
immunofluoresc
label
immunoprecipit
immunoblot
analys
reveal
cultur
spodoptera
frugiperda
sf
cell
produc
immun
reactiv
hemagglutinin
infect
recombin
viru
digest
endoglycosidas
hand
f
show
hemagglutinin
glycosyl
oligosaccharid
process
hemagglutinin
express
cell
surfac
hemolyt
capac
activ
posttransl
proteolyt
cleavag
chicken
immun
sfcell
express
hemagglutinin
develop
hemagglutin
inhibit
neutral
antibodi
protect
infect
fpv
hemagglutinin
gene
also
express
larva
tobacco
budworm
gene
product
found
biolog
activ
observ
demonstr
hemagglutinin
synthes
process
cultur
insect
cell
whole
anim
similar
fashion
fpvinfect
vertebr
cell
full
biolog
activ
kistner
c
schol
tissek
inst
f
virologi
justusliebiguniv
gielsen
nucleoprotein
influenza
virus
phosphoprotein
vivo
phosphoryl
influenc
phorbol
ester
tpa
phosphopeptid
pattern
obtain
tryptic
map
show
specif
differ
presenc
absenc
tpa
tpa
shown
stimul
proteinkinas
c
enzym
also
phosphoryl
isol
nucleoprotein
vitro
result
combin
calcium
influx
accumul
diacylglycerid
hour
infect
suggest
proteinkinas
c
play
role
replic
cycl
influenza
virus
rott
r
tashiro
inst
f
virologi
justusliebiguniv
giefsen
sever
strain
staphylococcu
aureu
staph
found
secret
serin
proteas
activ
influenza
virus
iv
proteolyt
cleavag
hemagglutinin
mice
coinfect
intranas
appropri
strain
iv
staph
anim
came
fatal
pneumonia
infect
iv
staph
alon
induc
relev
patholog
chang
low
titer
viru
could
found
lung
mice
infect
viru
alon
howev
addit
trypsin
lung
homogen
increas
infect
tissu
sampl
coinfect
staph
produc
high
viru
titer
lung
could
increas
vitro
treatment
trypsin
thu
coinfect
bacteia
play
essenti
role
develop
influenza
pneumonia
provid
proteas
suitabl
cleavag
activ
hemagglutinin
serolog
influenzadiagnosi
comparison
cft
subtyp
immunoglobulin
class
specif
doller
g
p
c
doller
hj
gerth
hygienelnst
abt
f
med
virologi
u
epidemiologi
tiibingen
low
titer
obtain
cft
usual
method
influenza
serodiagnosi
allow
differenti
acut
remot
infect
rule
differenti
possibl
subtyp
immunoglobulin
class
specif
show
result
patient
confirm
influenzainfect
individu
immun
respons
influenzainfect
vari
consider
patient
produc
igg
iga
igmantibodi
iggand
igaantibodi
iggantibodi
lftpositivecftneg
react
cftpositiveiftneg
react
patient
neither
cft
antibodi
detect
despit
viru
isol
total
patient
possibl
detect
acut
influenzainfect
cft
condit
viral
surfac
antigen
secret
vitro
hela
cell
produc
secret
three
surfac
protein
filament
particl
data
suggest
secret
larg
protein
requir
excess
small
protein
ii
high
proport
larg
protein
favour
format
filament
addit
nm
particl
iii
express
larg
protein
regul
celltyp
specif
way
studi
immun
hepat
b
surfac
antigen
hbsag
cellular
level
peripher
blood
lymphocyt
isol
day
vaccin
hepat
b
vaccin
hbvax
msd
lymphocyt
cultur
day
absenc
presenc
pokewe
mitogen
pwm
cultur
supernat
analys
specif
antibodi
hbsag
antihb
total
igg
total
igm
enzym
immunoassay
vaccin
antihb
detect
wherea
antihb
could
measur
day
higher
extent
day
vaccin
pwm
inhibit
synthesi
antihb
influenc
pwm
upon
synthesi
total
igg
total
igm
vari
consider
antihb
concentr
follow
person
vaccin
hepat
b
vaccine
initi
seroconvert
antibodi
level
declin
lull
within
year
shown
earlier
smaller
group
persist
antihb
depend
maxim
antibodi
respons
measur
week
third
immunis
rate
decreas
antihb
seem
similar
person
without
influenc
age
sex
dose
vaccin
revaccin
done
person
antihb
level
lull
within
day
booster
dose
antihb
increas
rapidli
lead
vaccine
antihb
concentr
consider
higher
first
booster
fibroblast
chastona
j
de
g
siegl
lnst
hygien
med
microbiolog
bern
one
step
growth
condit
first
sign
viral
metabol
activ
detect
day
onset
infect
therefor
earli
event
adsorpt
time
viral
synthesi
initi
togeth
part
slow
process
furthermor
hav
replic
highli
protract
viral
metabol
activ
basic
occur
first
two
week
infect
thereaft
cell
remain
persist
infect
synthesi
total
viral
rna
ie
neg
strand
templat
rna
genom
rna
viral
rna
well
synthesi
encapsid
genom
rna
occur
parallel
appear
accumul
progeni
infecti
viru
appear
subgenom
vrna
nucleotid
long
close
associ
ribosom
yet
anoth
featur
distinguish
hav
typic
picornavirus
krech
g
siegl
lnst
hygien
med
microbiolog
bern
hepat
viru
hav
share
mani
characterist
picornavirus
genom
consist
linear
singlestrand
rna
messengersens
polar
howev
unlik
picornavirus
hav
fail
shut
host
cell
metabol
henc
analysi
viral
protein
synthesi
meet
difficulti
circumv
situat
havenom
rna
translat
rabbit
reticulocyt
system
optim
respect
k
mg
trna
viral
rna
concentr
kinet
translat
hav
rna
polioviru
rna
prove
similar
period
min
translat
product
hav
rna
consist
least
polypeptid
mwt
kd
seven
mwt
kd
becam
evid
within
first
min
translat
five
larger
one
accumul
min
process
polypeptid
larger
kd
far
observ
role
iinterferon
pathogenesi
hepat
viru
infect
maier
k
vallbracht
p
gabriel
b
flehmig
hygienelnst
dept
med
virolog
tiibingen
peripher
blood
lymphocyt
pbl
collect
patient
suffer
acut
hepat
viru
hav
infect
differ
time
onset
icteru
cell
popul
express
cytotox
activ
autolog
havinfect
skin
fibroblast
capac
releas
ylfn
upon
stimul
havinfect
fibroblast
pbl
incub
uninfect
fibroblast
pbl
antihay
neg
person
incub
autolog
havinfect
fibroblast
produc
ylfn
specif
lysi
also
could
detect
although
highest
activ
havspecif
lysi
demonstr
week
onset
icteru
strongli
correl
height
lfnproduct
coincid
paramet
indic
cytotox
tcell
product
ylfn
might
attribut
elimin
havinfect
man
hepatotrop
dna
virus
hbv
dhbv
gshv
character
small
circular
dna
genom
kbp
length
mechan
replic
central
featur
revers
transcript
rna
intermedi
minu
strand
dna
specif
detect
replic
intermedi
viral
transcript
strandspecif
dhbv
probe
prepar
dhbv
f
dna
kbp
length
ligat
psp
dna
eco
rl
posit
recombin
dna
molecul
clone
transform
e
coli
hb
dhbv
dna
posit
transform
two
select
contain
dhbv
dna
insert
differ
orient
determin
restrict
enzym
analysi
rna
probe
synthes
two
clone
specif
detect
viral
mrna
viral
minu
strand
replic
dna
speci
respect
probe
use
studi
viral
replic
transcript
viral
gene
add
understand
biolog
dhbv
hepatocyt
well
nonhepatocyt
bosch
valeri
g
radziwil
h
schaller
heidelberg
pframe
hepat
b
viru
presum
code
protein
involv
viral
replic
howev
neither
natur
put
product
mode
biosynthesi
elucid
approach
problem
segment
sum
duck
hepat
viru
dhbv
pframe
express
fusion
protein
e
coli
antisera
prepar
peptid
antifus
protein
sera
contain
signific
titr
toward
respect
psegment
could
also
imrnunoprecipit
pvspecif
polypeptid
synthes
vitro
intact
viral
core
contain
dhbvdna
endogen
polymeras
activ
immunoprecipit
infect
duck
liver
use
anticapsid
c
serum
neither
western
blot
larg
amount
ilgc
materi
immunoprecipit
radioiodin
reveal
vivo
synthes
pproduct
reason
neg
find
still
unclear
pekin
duck
model
hepat
b
conveni
system
studi
viral
replic
antivir
strategi
detail
character
viral
nucleic
acid
speci
dhbv
genom
clone
serum
dhbv
isol
ultracentrifug
serum
viral
genom
extract
linear
eco
ri
ligat
pbr
dna
e
coli
hb
transform
recombin
dna
dhbv
dnaposit
coloni
plasmiddhbv
dna
prepar
kbp
dhbv
dna
insert
purifi
physic
structur
establish
restrict
enzym
analys
restrict
pattern
dhbv
dna
f
ident
dhbv
dna
mandart
et
ai
differ
significantli
dhbv
dna
sprengel
et
ai
use
clone
viral
dna
probe
viral
dna
speci
infect
serum
liver
analyz
molecular
hybrid
techniqu
congenit
infect
duck
high
level
viral
dna
serum
gradual
declin
month
mechan
reduct
viral
particl
serum
correl
viral
replic
liver
present
investig
fuch
transcript
woodchuck
hepat
viru
whv
member
hepadnaviru
famili
studi
liver
carcinoma
chronic
infect
woodchuck
marmota
monax
replic
whvdna
studi
tumor
nontumor
liver
southern
blot
ten
tumor
without
viral
replic
transcript
studi
northern
blot
rna
tumor
hybridis
subgenom
fragment
whvdna
clone
gemini
vector
clone
contain
singl
read
frame
part
seven
tumor
two
major
rna
transcrib
kb
shown
chronic
infect
liver
moray
et
al
sometim
larger
transcript
observ
transcript
despit
presenc
whvdna
could
detect
one
tumor
two
tumor
integr
whvdna
one
major
transcript
ego
could
seen
hybridis
subgenom
clone
reveal
tumor
transcript
contrast
chronic
infect
liver
cgene
part
presigen
delet
hepat
delta
viru
hdv
protein
identifi
immunoblot
use
hd
patient
sera
sourc
antibodi
two
protein
copurifi
hdv
particl
serum
acut
infect
chimpanze
protein
also
found
sera
virem
hd
patient
hd
infect
woodchuck
detect
hd
protein
immunoblot
marker
hd
viremia
superior
detect
hd
antigen
elisa
possibl
even
presenc
excess
hd
antibodi
also
found
hd
infect
liver
miss
howev
variabl
pattern
hd
reactiv
protein
observ
protein
predominantli
local
nucleu
woodchuck
liver
found
bound
rna
rasshof
r
c
pahlk
buil
roggendorf
max
v
pettenkof
inst
univ
ciutat
sanitaria
vall
dhebron
barcelona
spain
hepat
delta
viru
hdv
defect
viru
need
hbv
helper
hdv
compos
circular
rna
kb
delta
antigen
coat
hdv
hb
ag
hdv
power
pathogen
simultan
infect
hbv
superinfect
chronic
hbsagcarri
caus
seriou
liverdamag
superinfect
chronic
hbsag
carrier
hdv
often
result
chronic
activ
hepat
cirrhosi
hdv
infect
diagnos
detect
hd
ag
antihdigm
igg
sinc
recent
nucleic
acid
hybridis
rna
specif
probe
studi
hybridisationcondit
hdvrna
optim
strandspecif
probe
like
primerextensionprob
show
much
higher
sensit
nicktransl
probe
howev
riboprob
use
problem
background
hybridis
aris
character
hdvrna
northernblot
show
typic
band
kb
contain
genom
antigenom
rna
minor
speci
rna
predomin
one
band
kb
speci
contain
genom
rnahdvrna
found
serum
patient
chronic
activ
hepat
cirrhosi
antihdigm
patient
hd
ag
liver
hdvrnaneg
patient
also
hdag
liver
antihdigm
serum
hdv
rnaposit
patient
hbvdna
serum
character
protein
associ
hepat
delta
viru
hdv
roggendorf
b
bohm
r
rasshof
c
pahlk
max
v
pettenkof
inst
univ
munchen
number
size
protein
associ
hdv
serum
liver
chimpanze
acut
stage
hdv
infect
analyz
immunoblot
hdv
posit
serum
sediment
sucros
gradient
hdvassoci
antigen
hdag
hbsag
determin
fraction
elisa
ria
peak
fraction
hdag
pool
subject
sd
page
subsequ
blot
nitrocellulos
hdvassoci
protein
detect
incub
human
antihd
posit
serum
protein
two
protein
kd
visual
immunoblot
immunoblot
hdag
extract
liver
tissu
chimpanze
guanidinium
hci
result
two
protein
kd
extract
human
liver
patient
chronic
hdv
infect
kd
size
howev
direct
homogen
chimpanze
human
liver
boil
mix
subject
page
subsequ
western
blot
result
two
major
protein
band
kd
data
indic
hdv
protein
unstabl
rapidli
degrad
smaller
fragment
structur
analysi
core
polypeptid
primat
lymphotrop
retrovirus
plrv
jurkiewicz
l
e
h
nakamura
j
schneider
l
hayami
c
hunsman
l
deutsch
primatenzentrum
kellnerweg
inst
med
scienc
univ
tokyo
japan
sever
monkey
speci
antibodi
crossreact
human
tcell
leukemia
viru
type
htlvi
main
core
polypeptid
primat
iymphotrop
retrovirus
plrv
similar
molecular
weight
discrimin
individu
plrv
compar
two
dimension
tryptic
peptid
map
core
polypeptid
ten
isol
origin
human
six
simian
speci
peptid
map
show
homolog
htl
vi
relat
isol
accord
relationship
peptid
map
classifi
plrv
three
group
human
chimpanze
isol
macaqu
virus
green
monkey
viru
contrast
hiv
human
immunodefici
viru
relat
simian
isol
siv
complet
differ
htlvi
relat
isol
therefor
repres
separ
group
plrv
respect
isol
african
green
monkey
sivagm
close
relat
hiv
virus
sooti
mangabey
sivsm
rhesu
monkey
sivmac
howev
sivsm
sivmac
close
relat
sivagm
hiv
casserbett
v
erfl
schmidt
abt
f
molekular
zellpathologi
gesellsch
f
strahlenu
umweltforschung
target
cell
oa
mulv
effect
viru
infect
bone
cell
studi
use
primari
skeletoblast
cell
cultur
neonat
oa
mulv
infect
nmri
mice
vitro
infect
primari
bone
cell
cultur
perman
osteoblast
cell
line
mc
seven
day
infect
nmri
mice
cell
obtain
fraction
dissoci
calvaria
cultur
earli
fraction
contain
lesser
differenti
osteoblast
cell
show
higher
rate
infect
late
fraction
differenti
osteoblast
cell
osteoblast
differenti
follow
alkalin
phosphatas
activ
alp
higher
cultur
infect
mice
control
vitro
infect
primari
cultur
periosteum
result
decreas
cell
growth
associ
increas
osteoblast
differenti
differenti
calfaria
cell
influenc
viru
infect
infect
mc
cell
follow
reduct
alp
activ
associ
increas
cell
growth
howev
cell
still
respons
chemic
induct
differenti
data
indic
bone
tissu
undifferenti
progenitor
cell
target
oa
mulv
viru
infect
increas
osteoblast
activ
fact
possibl
explain
critic
role
oa
mul
v
bone
tumorigenesi
contrast
infect
perman
mc
osteoblast
cell
follow
revers
block
differenti
schmidt
j
luz
e
livn
silbermann
v
erfl
abt
f
molekular
zellpathologi
inst
pathologi
gesellsch
israel
inst
technologi
technion
haifa
israel
mandibular
condyl
neonat
mice
repres
socal
secondari
type
cartilag
contain
welldefin
cell
layer
differ
state
differenti
vitro
bipotenti
precursor
cell
present
tissu
shift
differenti
program
express
alkalin
phosphatas
collagen
type
bone
sialoprotein
osteonectin
final
becom
bone
cell
twentyfour
hour
vitro
infect
mandibular
condyl
fbr
msv
cell
progenitor
cell
layer
found
infect
cultiv
result
increas
loss
cellular
organ
polymorph
miner
remnant
cartilag
matrix
invas
growth
fibroblast
perichondr
cell
condylar
tissu
underlay
collagen
spong
seven
day
infect
tissu
acquir
appear
osteosarcomat
lesion
implant
infect
mandibular
condyl
syngen
mice
transplant
fibrochondrosarcoma
tumor
line
establish
tumor
induct
could
observ
fbr
msv
infect
similar
tissu
meckel
cartilag
xiphoid
data
suggest
presenc
chondroprogenitor
cell
condylar
tissu
inhabit
capac
bidirect
differenti
prerequisit
fbr
msvinduc
osteosarcomagenesi
vitro
system
facili
detail
morpholog
molecular
analysi
earli
step
viral
osteosarcomagenesi
inst
immunobiolog
univ
freiburg
friend
murin
leukemia
viru
fmulv
caus
erythroleukemia
mice
order
studi
biolog
viru
function
gene
sequenc
genom
highli
infecti
fmulv
polymeras
gene
viru
code
proteas
revers
transcriptas
endonucleas
sequenc
obtain
show
high
degre
homolog
moloney
murin
leukemia
viru
akv
sequenc
code
proteas
revers
transcriptas
contrast
sequenc
code
carboxyterminu
endonucleas
much
less
conserv
might
repres
specif
viral
integr
host
genom
knowledg
sequenc
allow
studi
function
defin
region
genom
leukemogenesi
schulz
n
hess
r
friedrich
inst
immunobiolog
univ
freiburg
heinrich
pett
inst
univ
hamburg
induct
diseas
murin
leukemia
virus
assum
involv
insert
activ
cellular
gene
local
newli
integr
viru
hamper
presenc
larg
number
endogen
virus
cellular
genom
tool
studi
local
possibl
common
integr
site
friend
murin
leukemia
viru
determin
possibl
activ
cellular
gene
construct
viru
contain
select
marker
bacteri
supressor
trna
gene
supf
insert
ltr
without
destroy
biolog
function
cell
transfect
dna
obtain
sever
cell
clone
produc
infecti
viru
viru
collect
cell
inject
suscept
mice
tumor
develop
use
prepar
genom
librari
use
screen
supf
harbour
provirus
facilit
determin
possibl
common
integr
site
werner
baier
j
lower
r
kurth
paulehrlichinst
frankfurt
cours
studi
antibodi
human
sera
hiv
occasion
observ
reactiv
viral
person
without
risk
contract
correspond
viru
infect
reactiv
viral
detect
sensit
western
blot
usual
elisa
extens
initi
observ
htlv
retrovirus
mammalian
baboon
endogen
viru
bev
friend
murin
leukemia
viru
flv
chicken
rou
sarcoma
viru
rsv
employ
antigen
sucros
densitygradi
band
virus
well
purifi
major
gagantigen
use
could
easili
demonstr
gag
protein
mammalian
retrovirus
recogn
antibodi
peopl
suffer
hiv
infect
also
patient
multipl
sclerosi
neurolog
diseas
teratocarcinoma
even
healthi
blood
donor
contrast
rsv
recogn
present
determin
proport
human
sera
react
anim
retroviru
gagantigen
whether
diseasespecif
pattern
observ
origin
gagreact
antibodi
remain
obscur
present
either
observ
biolog
trivial
true
crossreact
may
howev
playa
practic
role
sensit
serodiagnost
procedur
reactiv
interspeciesspecif
antibodi
form
respons
yet
unknown
endogen
exogen
human
retroviru
strain
investig
express
protooncogen
csrc
cellular
homolog
rou
sarcoma
viru
transform
gene
vsrc
previou
result
csrc
express
ontogenesi
vertebr
suggest
physiolog
function
csrc
appear
close
relat
differenti
process
prolifer
process
statement
support
data
obtain
experi
pro
myelocyt
human
cell
line
induct
monocyt
granulocyt
differenti
cell
tpa
retino
acid
ra
dimethylsulfoxid
dmso
associ
activ
c
src
kinas
increas
csrc
gene
express
control
experi
exclud
interact
tpa
dmso
tyrosinespecif
c
src
kinas
use
embryon
carcinoma
cell
line
also
induc
differenti
vitro
current
analyz
whether
differentiationdepend
express
csrc
gene
product
restrict
monomyelocyt
cell
gener
observ
cellular
differenti
process
studi
express
csrc
csrc
relat
gene
chicken
cdna
librari
establish
screen
kb
pvuii
fragment
vsrc
posit
clone
obtain
restrict
analysi
hybrid
experi
reveal
clone
deriv
genet
locu
howev
differ
locu
csrc
gene
largest
srcrelat
cdna
clone
kb
sequenc
show
homolog
vsrc
comparison
publish
dna
sequenc
reveal
homolog
known
tyrosin
kinas
especi
isk
tyrosin
kinas
isol
lstra
cell
line
northern
blot
studi
kb
clone
hybrid
kb
mrna
chicken
embryo
fibroblast
signal
size
ws
obtain
bishop
pvull
fragment
vsrc
assum
csrc
mrna
basi
result
present
kb
cdna
clone
repres
novel
tyrosin
kinas
gene
furthermor
express
uf
src
requir
investig
attenu
control
cmyc
gene
express
eick
g
w
bornkamm
inst
f
virologi
zentrum
f
hygien
univ
freiburg
dmso
dimethylsulfoxid
potent
induc
differenti
cell
caus
rapid
decreas
cytoplasm
steadi
state
cmyc
rna
decreas
regul
mainli
level
transcript
elong
elong
block
within
untransl
cmyc
leader
propos
crnyclead
abl
undergo
two
altern
conform
onestemandioop
structur
allow
readthrough
rna
polymeras
code
part
crnyc
gene
twosternandloop
structur
caus
transcript
arrest
compar
attenu
model
gene
simian
viru
restrict
endonucleas
electron
microscop
heteroduplex
analys
clone
dna
sequenc
ijoy
maba
strain
epsteinbarr
viru
ebv
reveal
sever
region
partial
nonhomolog
open
read
frame
locat
featur
allow
differenti
type
ebv
report
describ
addit
region
diverg
caus
base
pair
bp
insert
bp
downstream
ijoy
exon
compar
ebv
dna
sequenc
insert
flank
bp
direct
repeat
constitut
truncat
duplic
mismatch
adjac
sequenc
side
structur
characterist
primari
secondari
insert
surround
genom
region
indic
deriv
alufamili
human
interspers
repeat
sequenc
hartl
p
lipp
inst
f
biochemi
ludwigmaximiliansuniv
miinchen
anaylz
burkitt
lymphoma
line
reciproc
transloc
join
immunoglobulin
kappa
light
chain
locu
chromsom
cmyc
gene
chromosom
breakpoint
two
marker
chromosom
sq
within
conserv
nonam
heptam
recombin
sequenc
signal
detect
directli
adjac
breakpoint
sequenc
chromosom
suggest
transloc
catalyz
enzym
normal
involv
v
recombin
distanc
cmyc
gene
breakpoint
amount
least
kb
dna
level
one
allel
cmyc
gene
somat
mutat
found
promoterlead
region
allel
trancrib
suppos
involv
transloc
use
transient
express
assay
function
differ
cmyc
promot
isol
allel
could
detect
variou
cell
type
result
suggest
burkitt
lymphoma
transloc
occur
earli
stage
bcell
differenti
cmyc
activ
locat
ig
chromatin
structur
epsteinbarrviru
ebv
infect
cell
induc
treatment
tpa
chemic
biolog
induc
express
earli
antigen
ea
produc
viru
induct
raji
cell
nonproduc
cell
line
deriv
african
burkitt
lymphoma
lead
express
ea
activ
strong
induc
region
part
duplic
ebv
genom
dr
studi
detail
could
shown
nuclear
runon
assay
treatment
raji
cell
tpa
iudr
activ
transcript
drregion
kb
rna
encod
region
detect
hour
induct
shown
northern
blot
analysi
induct
protein
synthesi
depend
indic
gene
function
either
ebv
cellular
requir
activ
drpromotercatconstruct
transient
transfect
ebv
posit
neg
lymphoid
cell
test
cat
activ
treatment
variou
ebv
induc
agent
construct
could
activ
ebv
posit
cell
indic
least
part
function
requir
activ
orregion
encod
ebv
mani
case
burkitt
lymph
oma
translocat
ion
murin
plasmacytom
crnyc
gene
truncat
suggest
sepa
ration
bod
gene
physiolog
prom
oter
upstream
regulatori
sequenc
one
impo
rtant
mechan
ism
lead
ing
cmyc
deregul
fact
crnyc
mrna
disappear
earl
induct
differenti
variou
cell
system
suggest
regulatori
ro
le
cmyc
gene
product
option
cell
either
prol
ifer
undergo
differenti
burkitt
lymphoma
cell
show
morpholog
phen
otyp
chang
cha
racterist
bcell
differenti
ation
respons
sodium
butyr
potent
induc
differenti
variou
cell
system
report
treatment
varieti
differ
burkitt
lymphoma
cell
line
sodium
butyr
irrespect
type
transloc
associ
epsteinbarr
viru
lead
rapid
decreas
cmyc
steadi
state
mrna
due
reduc
tran
cripti
rate
crnyc
gene
shown
nuclear
runon
ana
lysi
fact
sodium
yrate
capab
le
downregul
intact
well
trun
cate
cmyc
gene
indic
import
target
site
tra
nscriptio
nal
regulat
ion
locat
downstream
dual
prom
oter
first
exon
jijoy
epstein
barr
viru
ebv
strain
character
substitut
kb
ctermina
l
part
ebn
gene
compar
maba
viru
protei
n
immunoblot
analysi
use
human
ebna
posit
sera
indic
immunolog
var
iant
ebna
type
encod
jijoy
viru
type
b
order
gener
specif
ebna
antiserum
naeilnsii
dna
fragment
ijoy
viru
contain
bp
cterminu
th
e
ebna
gene
clone
e
coli
express
vector
pm
result
fusion
prote
contain
cterm
inal
amino
acid
viral
prot
ein
dalton
part
bacteri
anthranil
synt
hase
rabbit
antisera
gener
fusion
protein
react
specif
two
prot
ein
dalton
jijoy
cell
three
cell
line
carr
ying
type
b
viru
prot
ein
could
identifi
type
b
cell
line
bl
addit
use
se
sera
direct
pme
fusion
prote
reacti
could
observ
ebna
prot
ein
sever
ot
cell
line
contain
type
viru
therefor
rabbit
sera
seem
use
specif
l
fur
ther
investig
boo
h
r
berger
c
kukukroo
andn
muellerlantzsch
inst
f
virologi
zentrum
f
hygien
freiburg
bnlflc
read
frame
ebv
genom
known
code
part
membran
protein
dalton
express
latent
infect
cell
line
lmp
unidentifi
protein
presum
dalton
antisera
protein
gener
rabbit
sera
react
protein
vari
size
dalton
found
ebv
harbour
cell
line
examin
far
addit
second
protein
dalton
sdspage
maba
cell
identifi
furthermor
sera
exhibit
posit
cytoplasm
immunofluoresc
cell
depend
cell
line
examin
analys
nonproduc
cell
line
raji
number
immunofluoresc
posit
cell
amount
dalton
protein
rapidli
increas
addit
fresh
medium
fetal
calf
serum
tumour
promot
tpa
even
higher
extent
nbutyr
synergist
effect
tpa
butyr
could
observ
kinet
induct
reach
maximum
h
addit
medium
fresh
serum
tpa
orland
nbutyr
decreas
h
lack
synerg
mention
differ
express
kinet
lmp
eakomplex
follow
induct
ebv
lytic
cycl
lmp
seem
member
eacomplex
despit
induc
use
comput
program
predict
secondari
structur
protein
superimpos
valu
hydrophil
surfac
probabl
flexibl
identifi
potenti
membran
protein
deriv
open
read
frame
encod
eb
viral
genom
antigen
site
four
membran
protein
encod
open
read
frame
bllfl
bilfl
select
oligopeptid
synthes
solid
phase
peptid
synthesi
pep
tide
use
antigen
elisa
assay
screen
sera
npc
infecti
mononucleosi
patient
healthi
individu
sera
npc
infecti
mononucleosi
patient
show
elev
reaction
peptid
highest
reaction
found
peptid
npc
patient
bllfladeriv
peptid
fresh
infect
low
antibodi
titer
could
identifi
peptid
read
frame
bilfl
immun
rabbit
nlljtermin
amino
acid
peptid
coval
link
palmit
acid
hightit
antisera
individu
oligopeptid
could
obtain
rabbit
sera
use
identif
correspond
eb
viral
protein
western
blot
imrnunoprecipit
immunofluoresc
support
sfb
tp
diagnosi
ebvcorrel
diseas
chose
five
relev
antigen
ebv
vca
ea
ea
bmrfi
bkrfl
code
sequenc
antigen
analys
comput
program
predict
antigen
site
clone
e
coli
case
cho
chines
hamster
ovari
cell
product
test
antigen
stabil
immunoblot
identifi
recombin
antigen
purifi
gel
filtrat
ion
exchang
chromatographi
hplc
purifi
ebv
protein
evalu
western
blot
follow
antibodi
class
specif
stain
use
elisatest
order
screen
sera
ebvneg
individu
patient
acut
ebv
infect
reconvalesc
patient
nasopharyng
carcinoma
result
combin
diagnost
signific
suggest
antigenantibodi
class
specif
test
combin
deriv
variou
condit
support
part
bmft
open
read
frame
span
bamhi
fragment
v
rightward
orient
late
activ
promot
map
bamhi
fragment
baer
et
al
singlestrand
dna
mb
clone
contain
sever
hundr
base
pair
select
mrna
protein
prove
transcript
mrna
rightward
orient
northern
blot
analyz
transcript
gene
prove
encod
charater
protein
express
end
fusion
protein
galactosidas
e
coli
latter
partial
purifi
use
immun
rabbit
fusion
protein
recogn
pool
sera
patient
nasopharyng
carcinoma
western
blot
use
rabbit
serum
abl
character
protein
late
protein
western
blot
immunoprecipit
support
dfg
two
major
envelop
protein
ebv
encod
read
frame
bllf
smaller
variant
gener
partial
splice
event
tumor
normal
individu
iggma
antibodi
detect
data
remov
intern
part
transcript
encod
yield
mrna
encod
two
protein
candid
ebvsubunit
vaccin
yield
express
recombin
cho
cell
high
amplif
ballfl
encod
sequenc
cell
possibl
perhap
due
toxic
effect
present
eukaryot
express
plasmid
construct
sequenc
encod
transmembran
anchor
region
remov
follow
transfect
cho
cell
plasmid
result
secret
ebv
membran
protein
cultur
medium
furthermor
amplif
methotrex
select
success
yield
high
level
express
max
v
pettenkoferinst
munchen
protein
encod
open
read
frame
connect
target
cytotox
tcell
reaction
direct
ebvinfect
lymphocyt
due
northern
dot
blot
experi
gene
transcrib
latent
infect
cell
addit
nuclear
antigen
ebna
one
polypeptid
characterist
membran
protein
use
sera
synthet
oligopeptid
deriv
amino
acid
sequenc
could
show
protein
synthes
burkitt
lymphoma
cell
line
truncat
form
lack
amino
acid
amino
termin
end
modrow
wolf
pna
use
antipeptid
sera
immunofluoresc
test
latent
infect
cell
line
posit
reaction
cell
obtain
similar
amount
produc
cell
could
identifi
situ
hybrid
use
label
dna
probe
sinc
latent
viral
product
ebna
detect
cell
suggest
may
typic
product
latent
ebv
infect
protein
express
cell
respect
vivo
cell
elimin
cytotox
tcell
rare
case
combin
addit
factor
truncat
form
may
produc
cell
may
develop
lymphoma
presenc
iga
antibodi
membran
antigen
epstein
barrviru
test
sera
nasopharyng
carcinoma
patient
patient
tumor
npc
normal
individu
sera
npcpatient
show
posit
reaction
sera
control
group
neg
adsorpt
sera
staphylococcu
aureu
protein
npcpatient
igama
antibodi
titer
patient
indic
preadsorpt
sera
staph
aureu
protein
render
diagnost
test
significantli
sensit
detect
npc
use
trial
prognosi
patient
furthermor
data
show
import
antibodi
test
ebvir
membran
antigen
especi
avail
larger
amount
recom
peviou
experi
correl
protein
encod
bamhi
region
singl
open
read
frame
northern
blot
substanti
model
transcript
dna
area
deriv
hybridselect
translat
sequenc
data
baer
et
al
map
activ
promot
protein
synthesi
block
simultan
superinfect
bamhi
fragment
still
transcrib
differ
cell
line
kb
mrna
transcrib
left
part
fragment
detect
mrna
read
frame
translat
kd
protein
posttransl
modifi
kd
phosphoprotein
second
kb
mrna
transcrib
right
part
bamhi
fragment
read
frame
locat
identifi
protein
express
larg
part
read
frame
e
coli
fusion
protein
withgalactosidas
fusion
protein
recogn
pool
sera
npc
patient
western
blot
use
immun
rabbit
sera
use
character
protein
support
dfg
kb
hindlii
k
fragment
locat
delet
neighbour
fragment
hybrid
northern
blot
kb
mrna
isol
induc
raji
cell
raji
cell
superinfect
viru
protein
synthesi
block
simultan
superinfect
cycloheximid
anisomycin
mrna
characterist
switch
latenc
lytic
cycl
express
condit
kb
mrna
transcrib
hind
iii
k
fragment
consist
mainli
singl
open
read
frame
therefor
seem
encod
protein
express
immedi
superinfect
latent
infect
cell
express
half
read
frame
fusion
protein
galactosidas
e
coli
protein
partli
purifi
use
immun
rabbit
use
rabbit
serum
abl
immunoprecipit
kd
protein
raji
cell
superinfect
viru
earli
infect
sever
group
alreadi
map
code
region
ebna
bam
hi
kfragment
ebvdna
order
character
natur
epitop
ebna
protein
hind
iiiilfrag
ebv
strain
maba
cut
fragment
bp
use
dnase
fragment
clone
e
coli
express
vector
accord
three
read
frame
direct
end
lac
z
protein
transform
bacteri
coloni
express
specif
epitop
identifi
method
use
coloni
immunoblot
result
verifi
protein
immunoblot
method
two
differ
epitop
ebna
protein
could
detect
sequenc
analysi
local
epitop
differ
region
repetit
sequenc
region
code
ebna
protein
immun
rabbit
ebna
epitop
antiserum
obtain
react
specif
ebna
protein
differ
ebv
strain
immunoblot
cell
surfac
densiti
molecular
structur
hla
class
ii
antigen
burkitt
lymphoma
bl
cell
epstein
barr
viru
ebv
transform
lymphoblastoid
cell
line
lcl
establish
patient
examin
use
radioimmuno
assay
monoclon
antibodi
common
determin
class
molecul
found
fold
higher
densiti
hla
class
molecul
lcl
bl
cell
pair
studi
cell
pair
class
ii
antigen
also
express
higher
amount
lcl
addit
immunoprecipit
radiolabel
compon
subsequ
analysi
sdspolyacrylamid
gel
electrophoresi
reveal
qualit
differ
class
molecul
bl
lcl
cell
cell
pair
studi
observ
chang
hla
class
express
may
well
playa
role
immunolog
growth
control
ebvtransform
cell
allow
bl
cell
escap
immun
surveil
mechan
monensin
concentr
dependet
multipl
infect
found
prevent
dna
replic
human
cytomegaloviru
hcmv
well
product
viral
progeni
effect
drug
hcmv
dnasynthesi
fulli
revers
delay
addit
effect
h
postinfect
induct
viral
dna
polymeras
imped
inhibitor
monensin
affect
hand
dna
replic
herp
simplex
viru
analysi
proteinand
glycoprotein
synthesi
reveal
monensin
interf
product
number
hcmvspecif
polypeptid
use
monospecif
antiserum
evid
obtain
drug
interf
process
kd
glycopolypeptid
herpesvirus
differ
number
ie
gene
product
least
one
ie
protein
tran
activ
properti
mode
ie
proteindna
interact
result
promot
activ
unclear
follow
possibl
envisag
ie
protein
bind
dna
ie
protein
complex
bind
dna
ie
protein
bind
dna
interact
cellular
facor
iel
gene
product
mcmv
demonstr
activ
promotor
tran
examin
dnabind
properti
major
ie
protein
process
product
use
ctdnacellulosechromatographi
reveal
high
affin
dna
wherea
show
littl
dnabind
properti
dnabind
howev
requir
presenc
cellular
dnabind
factor
thu
direct
indirect
dnabind
prerequisit
regul
activ
promotor
regul
activ
either
direct
interact
indirect
factor
modif
pp
examin
iel
gene
product
involv
induct
earli
gene
express
earli
gene
must
identifi
isol
purpos
monoclon
antibodi
mab
earli
protein
mcmv
prepar
one
mab
stain
antigen
locat
cytoplasm
immunoprecipit
k
earli
protein
stain
second
mab
result
faint
homogen
nuclear
fluoresc
earli
phase
late
time
antigen
accumul
larg
aggreg
nucleu
mab
precipit
earli
protein
third
mab
produc
speckl
nuclear
stain
earli
phase
wherea
late
time
distribut
antigen
resembl
second
antigen
immunoblot
third
mab
show
earli
protein
immunoprecipit
mab
vitro
translat
earli
rna
reveal
protein
gene
express
mcmv
subdivid
three
coordin
regul
phase
immediateearli
ie
earli
late
protein
transactiv
promot
clear
whether
function
associ
gene
product
process
protein
regulatori
viral
protein
complex
format
function
often
associ
sediment
pattern
investig
earli
gene
express
allow
less
three
hour
protein
sediment
monom
delay
earli
h
pi
late
phase
detect
complex
cellular
protein
appear
involv
complex
format
possibl
particip
earli
protein
present
studi
event
delay
earli
phase
respons
complex
format
role
transactiv
unlik
sinc
found
bind
dna
potenti
recognit
cytolyt
lymphocyt
requir
analysi
scriba
l
ostberg
e
pursch
human
monoclon
antibodi
made
fusion
spaz
cell
mous
x
human
myeloma
either
peripher
blood
lymphocyt
patient
acut
cmv
infect
spleen
cell
stimul
vitro
cmv
antigen
prior
fusion
method
could
obtain
sever
hybridoma
secret
anticmv
antibodi
four
hybridoma
establish
stabl
produc
secret
tgml
antibodi
sinc
year
three
antibodi
neutral
antibodi
iggl
subtyp
th
antibodi
recogn
intern
structur
protein
viru
clinic
trial
prophylaxi
cmv
infect
bone
marrow
transplant
patient
initi
recent
neutral
antibodi
number
immediateearli
ie
gene
differ
among
differ
herpesvirus
least
one
ie
gene
product
necessari
initi
earli
phase
viral
gene
express
product
ie
gene
murin
cytomegaloviru
mcmv
activ
promot
tran
transcript
control
strong
enhanc
also
influenc
express
anoth
ie
gene
code
protein
immunoprecipit
murin
antisera
mcmv
ie
protein
could
detect
vitro
translat
hybridselect
rna
function
gene
product
unknown
therefor
first
step
gene
analyz
detail
protein
translat
kb
mrna
splice
molecul
contain
exon
n
n
n
n
exon
end
kb
mrna
open
read
frame
n
could
encod
polypeptid
amino
acid
calcul
molecular
weight
human
cytomegaloviru
hcmv
particl
contain
phosphoprotein
k
matrix
protein
appear
particularli
reactiv
western
blot
analys
human
antisera
gene
map
screen
bacteriophag
lambda
edna
express
librari
mono
specif
rabbit
antisera
subsequ
hybrid
edna
cosmid
plasmid
clone
contain
entir
hcmv
strain
genom
map
gene
hindiiifrag
j
n
genom
segment
transcrib
abund
late
kb
rna
nucleotid
sequenc
region
determin
transcript
initi
polyadenyl
site
transcript
locat
primer
extens
nucleas
protect
experi
polypeptid
secondari
structur
analysi
reveal
multiplepl
sheet
hydrophil
cluster
provid
possibl
explan
immunogen
properti
polypeptid
ernstrodenwaldtinst
koblenz
rnaclass
encod
within
immediateearli
ie
region
human
cytomegaloviru
strain
transcript
distinct
rna
hcmv
thu
far
describ
extens
northernblot
analys
demonstr
rna
present
rna
prep
phase
infecti
cycl
sjanalys
rnaseprotect
primer
extens
use
synthet
oligonucleotid
determin
addit
sequenc
establish
thu
provid
whole
nucleotid
sequenc
code
region
typic
polyadenyl
signal
found
upstream
put
initi
site
howev
typic
tat
abox
detect
sinc
longer
open
read
frame
found
sequenc
rna
might
regulatori
rather
proteincod
function
antibodi
envelopeprotein
human
cytomegaloviru
hcmv
schmitz
h
bruehmann
bernhardtnochtinst
hamburg
compar
immun
respons
hcmv
use
elisa
neutral
test
nt
antibodi
titer
human
sera
hyperimmunegamma
globulin
test
parallel
rel
low
correl
coeffici
r
found
addit
analyz
immun
respons
hcmv
glycoprotein
human
sera
use
monoclon
antibodi
character
immunofluoresc
immunoblot
nt
monoclon
use
obtain
enzymelabel
antigen
ela
glycoprotein
ela
look
specif
antibodi
activ
human
sera
time
close
correl
nttiter
found
therefor
enzym
immunoassay
use
select
blood
donat
hcmv
hyperimmunegamma
globulin
nih
subclon
clone
found
defici
respect
antiprolif
respons
well
antivir
effect
lytic
rnavirus
eg
encephalomyocard
viru
emcv
vesicular
stomat
viru
vsv
induct
synthetas
dsrna
depend
protein
kinas
ifn
well
inhibit
retroviru
product
eg
murin
leukemia
viru
mmulv
indic
defect
lack
function
ifn
receptor
low
level
depend
rnase
discuss
reason
defect
describ
develop
select
system
base
ifn
treatment
subsequ
viru
challeng
emcv
allow
isol
protect
coloni
deriv
unprotect
cell
popul
characteris
subclon
led
dose
respons
compar
ifn
sensit
l
cell
respect
emcv
contrast
vsv
protect
well
inhibit
cell
growth
much
less
extens
resembl
origin
nih
line
implic
least
partial
independ
mechan
lead
effect
differ
level
depend
nucleas
could
demonstr
impli
anoth
defect
besid
nonfunct
system
respons
partial
ifn
resist
origin
nih
line
infect
cultur
mous
bonemarrow
macrophag
newcastl
diseas
viru
cell
result
high
titer
ifn
x
reach
peak
level
h
follow
induct
multipl
result
infect
cell
determin
immunofluoresc
analysi
situ
hybrid
reveal
presenc
ifna
p
mrna
h
infect
cell
respect
h
infect
specif
hybrid
signal
seen
cell
strong
increas
number
grain
per
cell
observ
great
heterogen
grain
densiti
per
cell
observ
follow
hybrid
ifn
cdna
probe
howev
cell
label
homofen
hybrid
done
probe
code
mhc
antigen
addit
specif
hybrid
signal
found
noninduc
control
cell
absenc
detect
antivir
activ
correspond
cultur
supernat
suggest
low
amount
ifn
andar
synthes
constitut
cultur
mous
bonemarrow
macrophag
domkeopitz
p
straub
p
hagendorn
h
kirchner
inst
viru
research
german
cancer
research
center
splenic
macrophag
cultur
hsv
resist
mice
surviv
hsv
infect
vitro
contrast
macrophag
hsv
suscept
mice
complet
lyse
viru
resist
mediat
product
interferon
earli
infect
prolong
cultur
macrophag
mice
continu
produc
infecti
virion
indic
establish
persist
infect
time
interferon
undetect
howev
shown
addit
antiinterferon
serum
interferon
involv
mainten
persist
infect
acut
phase
viru
infect
induct
viral
protein
dna
replic
ident
macrophag
resist
suscept
mice
later
viral
dna
content
number
cell
express
hsv
antigen
decreas
macro
phage
mice
howev
singl
cell
remain
express
viral
protein
produc
infecti
particl
result
show
macrophag
persist
infect
hsv
due
genet
control
properti
fourtyf
patient
virolog
confirm
dendrit
kerat
treat
random
doubleblind
control
studi
basic
therapi
trifluorothymidin
tft
eye
drop
addit
receiv
differ
human
recombin
interferon
rhu
ifn
eye
drop
follow
result
obtain
averag
heal
time
tft
plu
one
drop
daili
rhu
ifnalpha
arg
million
iuml
day
tft
plu
rhu
ifngamma
million
iurnl
day
tft
plu
mixtur
alpha
plu
gamma
million
iuml
day
tft
plu
mixtur
alpha
plu
gamma
million
iuml
day
hightit
gamma
interferon
significantli
differ
hightit
alpha
interferon
combin
therapi
dendrit
kerat
mixtur
alpha
plu
gamma
moder
titer
million
iuml
effect
hightit
monoprepar
ad
lowtit
interferon
mixtur
gave
better
therapeut
result
antivir
monotherapi
thu
seem
possibl
save
interferon
commonli
use
combin
therapi
dendrit
kerat
appli
mixtur
differ
suitabl
interferon
instead
interferon
mono
speci
gr
u
n
j
barbara
zoller
er
na
kroon
c
jungwirth
molecular
mechani
sm
interferon
action
pox
viru
specif
immedi
earl
prot
ein
synthesi
studi
interferon
treat
chick
cell
condit
inhibit
pro
xviru
specif
thymidin
kinas
induct
rna
earl
enzym
synthes
accumul
northern
blot
analysi
reveal
strong
degrad
residu
thymidin
kinas
rna
blot
hybrid
izat
analysi
use
tot
al
vaccinia
dna
restr
iction
fragment
n
pro
be
demonstr
gener
reduc
steadi
state
amount
vaccinia
specif
earli
rna
int
erferon
treat
chick
embr
yo
fibroblast
express
chloramphenicol
acetyltransferas
gene
insert
infecti
vaccinia
recombin
inhibit
interferon
tr
eat
cell
br
andner
g
b
altinkil
c
llpp
lnst
f
virologi
univ
freiburg
biochemisch
lnst
univ
miin
chen
hsv
replic
sensit
ifn
cell
cultur
vivo
claim
observ
antivir
activitiy
hu
rtnf
certain
cell
line
hel
typic
vitro
antivir
assay
pretreat
tnf
led
protect
infect
vsv
emcv
hsv
observ
inhibit
cytopath
effect
virusyield
reduct
suppress
format
viral
protein
nsynthetas
enzym
induc
ifn
also
induc
tnf
confluent
ifnmrna
could
detect
northern
blot
analysi
rna
tnftreat
cell
antiifnantibodi
howev
present
pretreat
tnf
led
partial
reduct
antivir
tnfeffect
antiifna
antiifni
amount
induc
ifnplik
activ
suffici
account
observ
virusyield
reduct
suggest
antivir
activ
tnf
mous
macrophag
grown
spleen
cell
mice
found
sensit
interferon
ifn
activ
herp
simplex
viru
type
therefor
use
cell
investig
level
ifn
block
replic
hsv
protein
synthes
strongli
reduc
ifn
aact
earli
step
viral
replic
cycl
isol
infect
cell
nuclei
prior
begin
viral
replic
show
equal
level
hsvdna
pretreat
control
cell
result
rule
ifn
action
viru
uptak
runon
transcript
experi
reveal
delay
transcript
icpo
thymidinkinasegen
contrast
found
inhibit
total
steadi
state
level
throughout
replic
cycl
result
suggest
effect
ifn
aon
transcript
stabil
viral
rna
chronic
hsv
type
infect
bl
cell
b
ab
raji
viral
protein
synthes
continu
variabl
amount
growth
cycl
reisol
virus
chronic
infect
cell
line
show
chang
glycoprotein
pattern
syncytia
format
vero
cell
sever
month
persist
addit
human
anti
hsi
sera
cultur
media
infect
becom
latent
establish
latenc
viral
protein
synthesi
stop
rapidli
content
viral
dna
decreas
day
less
one
copi
per
cell
remov
antibodi
cell
show
characterist
chronic
infect
five
exoglycosidas
three
endoglycosidas
use
determin
glycosyl
pattern
relev
infect
hsyl
digest
exoglycosidas
yield
reduct
infect
log
unit
control
experi
could
shown
proteolyt
activ
detect
enzym
prepar
effect
fulli
glycosyl
virion
analysi
yield
decreas
rel
mol
wt
glycoprotein
expect
glycosidasetreat
digest
endo
h
result
decreas
infect
decreas
rel
mol
wt
gb
suggest
gc
gd
complextyp
glycosyl
ii
gb
glycosyl
highmannosetyp
manner
iii
remov
carbohydr
decreas
infect
digest
endo
f
decreas
infect
result
decreas
rel
mol
wt
viral
glycoprotein
experi
peg
could
restor
ceas
infect
suggest
endo
f
caus
block
infect
level
adsorpt
data
present
provid
evid
olink
carbohydr
might
play
role
infect
present
studi
protein
specif
antibodi
ab
structur
nonstructur
protein
analyz
wba
ripapag
sera
contain
antihsi
igm
test
classspecif
wba
ripapag
reactiv
igg
igm
ab
could
demonstr
igg
igm
ab
direct
viral
immediateearli
ie
earli
e
late
l
protein
follow
acut
primari
infect
earliest
igm
ab
respons
found
direct
viral
glycoprotein
subsequ
viral
nonglycosyl
structur
nonstructur
protein
recogn
igm
ab
alreadi
earli
infect
igg
ab
viral
glycoprotein
viral
structur
protein
appar
mw
kd
could
detect
viral
ie
e
protein
poorli
recogn
igg
ab
acut
primari
infect
acut
recurr
infect
igm
ab
exhibit
less
complex
pattern
reactiv
viral
protein
predominantli
viral
nonglycosyl
structur
protein
recogn
igm
abslgg
ab
patient
acut
recurr
hsvl
infect
react
strongli
varieti
viral
structur
nonstructur
protein
latent
infect
long
last
promin
ab
respons
gb
gd
could
shown
wherea
ab
viral
structur
nonstructur
protein
seem
produc
temporarili
seven
adult
two
neonat
mortal
diseas
unrel
hsv
dna
sampl
brain
tissu
g
separ
viral
high
densiti
cellular
low
densiti
fraction
two
cycl
csci
densiti
gradient
bam
hi
restrictogram
hybrid
hsv
type
fragment
u
l
bam
hic
tk
gene
q
junction
k
origin
us
n
gene
neonat
brain
free
hsv
dna
seven
tempor
grey
white
matter
adult
brain
two
brainstem
contain
hsv
dna
sequenc
found
viral
cellular
fraction
one
adult
brain
sampl
consist
linear
organ
hsv
genom
six
adult
brain
hsv
dna
exist
incomplet
form
novel
small
rna
hsv
infect
cell
eucaryot
cell
small
nuclearand
small
cytoplasm
rna
snor
scrna
associ
distinct
protein
form
snrnp
sncrnp
present
studi
analyz
protein
composit
well
small
rna
pattern
noninfect
herp
simplex
viru
type
infect
vero
cell
found
concomitantli
shut
host
cell
messeng
rna
synthesi
synthesi
usnrna
stop
due
stabil
howev
usnrna
still
present
hsv
infect
cell
h
pi
besid
rna
two
novel
small
rna
detect
infect
cell
term
hvri
base
rel
mobil
urea
gel
appar
chain
length
newli
synthes
rna
determin
nucleotid
respect
librari
small
fragment
hsvl
dna
estabish
express
vector
lambda
gtll
screen
monoclon
antibodi
direct
crossreact
epitop
present
glycoprotein
glycoprotein
gb
hsvl
use
one
lambda
clone
probe
could
shown
gene
map
colinearli
gb
gene
ul
segment
genom
could
demonstr
one
group
crossreact
epitop
cluster
region
approxim
amino
acid
nuceotid
sequenc
reveal
highli
conserv
region
gb
gene
hsvl
determin
nucleotid
sequenc
code
common
epitop
progress
attenu
live
vaccin
strain
rach
develop
fetal
isol
continu
propag
porcin
embryon
kidney
cell
passag
strain
rach
th
p
dna
prove
restrict
enzym
pattern
differ
ehvl
isol
strain
comparison
dna
prepar
high
low
passag
rach
strain
use
digest
restrict
enzym
bam
hi
least
th
passag
dna
pattern
show
similar
obtain
field
isol
dna
assum
mutat
result
alter
fragment
pattern
vaccin
strain
correspond
loss
virul
observ
propag
th
passag
gerritzen
k
e
schnewei
inst
med
microbiolog
immunolog
univ
bonn
mice
genit
infect
herp
simplex
viru
hsv
infecti
viru
isol
inflam
drain
lymph
node
contrari
posit
result
lumbosacr
ganglia
attempt
reactiv
abort
infect
eventu
establish
lymph
node
spleen
cell
stimul
phythaemagglutinin
lipopolysaccharid
render
posit
result
even
adult
immunodefici
mice
use
test
anim
isol
infecti
viru
lymph
node
spleen
cell
success
immatur
old
mice
particularli
undergon
pretreat
cyclophosphamid
silica
antimacrophag
serum
andor
cortison
day
pi
date
optimum
viru
yield
infect
mice
frequent
posit
genet
sensit
anim
resist
mice
data
indic
lymphohaematogen
spread
viru
inhibit
favour
neural
dissemin
mean
activ
defenc
mechan
probabl
macrophag
andor
nkcell
clin
microbiol
integr
genom
partial
tandem
special
suit
detail
studi
amplif
process
elona
permiss
tantigen
origin
replic
function
monoclon
antibodi
mab
direct
glycoprotein
bovin
herpesviru
type
crossreact
sever
serolog
test
human
herp
simplex
viru
type
antigen
hsi
involv
crossreact
identifi
glycoprotein
gb
indirect
immunofluoresc
use
urn
cryosect
infect
cell
mab
reveal
either
patchi
intranuclear
cytoplasm
membran
label
lmmunogold
lem
ultra
thin
cryosect
infect
cell
show
two
antibodi
detect
epitop
capsid
distinct
area
nuclei
wherea
stain
envelop
virus
cytoplasm
egress
western
blot
analysi
capsid
prepar
isol
differ
compart
infect
cell
agreement
hypothesi
gb
transport
nucleu
attach
capsid
investig
show
whether
biochem
differ
detect
gb
molecul
local
differ
cellular
compart
patient
organ
transplant
higher
risk
get
infect
eg
cytomegaloviru
herp
simplex
viru
varicella
zoster
studi
cours
kidney
transplant
patient
first
month
transplant
immunosuppress
therapi
ciclosporin
addit
virusspecif
titer
elisa
igg
igm
class
cmv
hsv
vzv
ratio
lymphocyt
peripher
blood
estim
far
ratio
shift
lower
valu
case
infecti
diseas
caus
eg
cmv
hsv
occur
day
week
later
would
mean
ratio
earlier
indic
outcom
infecti
diseas
appar
inappar
clinic
cours
could
seen
eg
seroconvers
virusspecif
igm
igg
ratio
nt
seem
influenc
ciclosporin
medic
liebig
univ
gielsen
sera
collect
year
ago
resid
republ
liberia
test
antibodi
marburgand
ebolaviru
use
elisa
immunoblot
techniqu
antibodi
marburg
viru
mv
found
ebola
viru
ev
distribut
seroposit
complet
independ
sex
tribal
affili
incid
antibodi
peopl
live
savannah
region
ten
year
amount
rest
popul
certain
divis
rubber
plantat
mani
peopl
seroposit
either
viru
highest
preval
infect
seen
age
group
year
indic
profession
risk
antibodi
virus
found
sera
ev
antibodi
occur
five
time
often
mv
posit
individu
whole
popul
ev
posit
sera
antibodi
mv
present
time
often
whole
popul
posit
correl
indic
must
exist
common
epidemiolog
risk
factor
infect
intracerebr
infect
sendaiviru
day
infect
brain
cell
cocultiv
uninfect
mice
brain
cell
persist
infect
cell
infecti
temperatur
sensit
ts
mutant
isol
mgia
protein
pattern
purifi
mgia
particl
differ
wildtyp
pattern
hemagglutin
hn
protein
band
promin
lower
molecular
weight
contrast
viral
protein
hnband
recognis
antisendai
serum
antihnmonoclon
antibodi
differ
due
genom
mutat
may
conclud
weak
hybridis
signal
hnmrnaspecif
cdna
probe
nt
correl
hnprotein
abund
studi
therol
hn
viral
persist
isol
tsmutant
sendai
wildtyp
viru
mutagenesi
fluoruracil
hnprotein
three
tsmutant
show
immunogen
properti
mgia
immunoblot
use
mutant
studi
cours
infect
mice
differ
cell
cultur
system
one
show
addit
reaction
nehallna
strain
also
sera
laboratori
rat
collect
last
ten
year
europ
differ
breed
coloni
test
hantaviru
strain
sera
posit
titer
rang
work
necessari
locat
natur
foci
hantaviru
clethrionomi
glareolu
western
germani
differ
cell
line
persist
infect
sendai
viru
investig
viral
infect
begin
persist
increas
infect
detect
could
explain
adapt
viru
host
cell
howev
although
compar
acut
infect
infect
four
magnitud
lower
viru
particl
capabl
multiplecycl
replic
nonpermiss
cell
later
stage
persist
lack
viral
infect
observ
contrast
acut
sendai
viru
infect
activ
obtain
trypsin
treatment
hand
small
number
viru
particl
activ
elastas
thermolysin
firid
appear
viru
popul
heterogen
consist
f
protein
mutant
could
conclud
infect
lost
sendai
viru
persist
due
lack
select
lead
heterogen
viru
popul
shown
recent
bud
measl
viru
connect
polar
growth
actin
filament
calcium
ion
known
playa
key
role
regul
assembl
disassembl
actin
filament
well
regul
contractil
therefor
calcium
ion
may
also
influenc
bud
process
measl
viru
modul
calcium
concentr
measl
viru
infect
cell
use
calcium
ionophor
presenc
calcium
magnesium
barium
ionophor
induc
l
disappear
viru
structur
microvilli
cell
surfac
random
redistribut
viru
hemagglutinin
cell
surfac
dissoci
nucleocapsid
protoplasm
membran
face
signific
reduct
cell
bound
infect
data
indic
calcium
ion
abl
influenc
morpholog
bud
viru
particl
plasma
membran
may
playa
role
viru
morphogenesi
support
part
gemeinniitzig
hertiestiftung
frankfurtm
insert
er
membran
set
free
precursor
cellular
signalas
remain
nonstructur
protein
set
free
differ
proteas
possibl
viru
specif
protein
contain
hydrophob
sequenc
could
function
transmembran
sequenc
find
accord
well
known
fact
flaviviru
protein
membran
associ
mechan
mediat
posit
neg
regul
transcript
adenoviru
earli
region
la
protein
present
unknown
whether
ela
gene
product
interact
rnapolymeras
ii
specif
dna
nucleotid
sequenc
enhanc
element
counteract
cellular
repressor
bound
viral
cellular
genom
remain
formal
possibl
order
verifi
one
possibl
interact
protein
mention
look
direct
indirect
bind
capabl
protein
doublestrand
ds
dna
nuclear
protein
extract
prepar
infect
kb
cell
pass
column
viral
cellular
ds
dnacellulos
elut
salt
gradient
fraction
screen
polypeptid
imrnunoprecipit
use
antipeptid
antibodi
detect
protein
mw
elut
column
kci
second
column
run
fraction
elut
salt
show
littl
bind
polypeptid
ds
dna
howev
incub
protein
contain
fraction
elut
first
column
nuclear
extract
uninfect
cell
restor
capabl
polypeptid
interact
viral
cellular
dna
suggest
bind
viral
protein
possibl
mediat
cellular
protein
current
character
bind
condit
possibl
sequenc
specif
cellular
compon
dnabound
viralcellular
protein
complex
support
deutsch
forschungsgemeinschaft
sfb
protein
adenovirsu
ad
involv
oncogen
transform
cell
exhibit
essenti
viral
function
product
infect
eg
dna
replic
transport
viral
mrna
shut
host
cell
protein
synthesi
sinc
limit
amount
protein
synthes
infect
cell
decid
express
gene
e
coli
express
system
also
offer
possibl
synthes
part
rais
antibodi
variou
domain
protein
investig
possibl
function
detail
express
vector
use
direct
transcript
synthet
promot
control
lac
oper
clone
code
ntermin
first
amino
acid
protein
fuse
bgalactosidas
total
protein
extract
transform
bacteria
contain
fusion
protein
expect
mw
addit
fusion
protein
express
clone
deriv
code
whole
protein
describ
protein
specif
degrad
e
coli
current
test
pin
gene
function
respect
stabil
protein
result
express
correspond
adenovir
protein
e
coli
specif
antibodi
direct
protein
dicuss
support
deutsch
forschungsgemeinschaft
sfb
establish
human
cell
line
express
protein
adenoviru
use
transfect
system
found
protein
bind
human
histocompat
antigen
hla
therebi
block
termin
glycosyl
transport
cell
surfac
reduc
level
class
antigen
cell
surfac
impair
tcell
recognit
cell
vitro
effect
found
normal
human
cell
infect
adenoviru
observ
mechan
might
import
establish
persist
infect
vivo
construct
express
hybrid
protein
allow
us
identifi
domain
class
antigen
necessari
associ
bind
domain
crucial
tcell
recognit
order
identifi
target
sequenc
within
ela
promot
requir
effici
transcript
activ
differ
promot
fragment
compar
transient
express
assay
far
two
import
posit
detect
delet
leftmost
bp
dna
reduc
el
promot
activ
delet
leftmost
bp
least
delet
dna
includ
invert
termin
repetit
itr
bp
function
import
transcript
tata
box
well
first
one
alon
presenc
earli
gene
product
overcom
reduct
itr
fragment
end
cat
gene
either
orient
restrict
control
element
dna
sequenc
posit
demonstr
serv
transcript
enhanc
transfect
increas
amount
dna
cat
construct
contain
promot
fragment
posit
result
maxim
cat
activ
rtg
transfect
dna
follow
rapid
promot
inactiv
smaller
promot
fragment
yield
increas
cat
activ
accod
increas
amount
transfect
dna
northern
analysi
suggest
control
mechan
occur
level
transcript
initi
two
limit
amount
occur
nuclear
protein
bhk
cell
bind
posit
identifi
gel
shift
test
factor
stimul
transform
hamster
cell
line
target
factor
could
map
el
cap
site
reconstitut
promot
garbrecht
sabin
ing
kruczek
inst
f
biochemi
order
isol
cellular
transcript
control
sequenc
transfect
bhk
cell
select
plasmid
contain
neo
gene
control
defect
promot
neo
without
eukaryot
promot
sequenc
psvo
neo
g
resist
cell
clone
isol
genom
analysi
show
multipl
insert
neo
gene
bhk
genom
order
obtain
singl
copi
integr
bhk
cell
transfect
dna
fragment
resist
cell
clone
northern
analysi
new
clone
show
compar
amount
neospecif
rna
accord
wt
rna
synthes
therefor
conclud
cellular
sequenc
function
complet
defect
promot
neo
facilit
clone
singl
copi
insert
site
tri
amplif
fusion
co
cell
transform
monkey
cell
contain
permiss
factor
tantigen
necessari
replic
case
amplif
fold
achiev
amplifi
dna
fragment
clone
puc
investig
inst
biochemistri
miinchen
simian
viru
larg
antigen
exist
multipl
molecular
form
separ
zone
veloc
sediment
solubl
extract
infect
monkey
cell
three
subclass
infect
cell
separ
character
newli
synthes
antigen
occur
form
monom
form
repres
tetra
mer
form
dimer
rate
oligomer
newli
synthes
antigen
tetram
vivo
greater
earli
time
infect
late
time
dna
bind
properti
subclass
investig
immunopurif
affin
form
dna
synthet
bp
sequenc
bind
site
similar
k
nm
specif
activ
dna
bind
greatest
subclass
least
subclass
moreov
specif
activ
form
increas
sharpli
h
infect
wherea
form
remain
constant
low
level
throughout
infect
bind
stoichiometri
antigen
consist
idea
stabl
tetram
bind
viral
dna
observ
low
bind
activ
deriv
contamin
dimer
model
relat
oligomer
dna
bind
antigen
infect
cell
present
lytic
infect
antigen
bind
specif
three
differ
region
dna
initi
dna
replic
regul
earli
late
transcript
construct
plasmid
contain
either
basepair
synthet
oligonucleotid
repres
site
ii
combin
bind
site
ii
iii
without
specif
flank
region
antigen
bound
site
high
affin
wherea
isol
site
ii
bound
specif
measur
specif
bind
could
restor
extent
combin
site
ii
flank
region
bind
site
iii
remain
weak
without
flank
sequenc
bind
dna
fragment
contain
site
ii
iii
higher
bind
fragment
either
ii
iii
ad
togeth
thu
flank
region
bound
directli
antigen
could
influenc
bind
affin
probabl
chang
dna
structur
nearbi
bind
site
montenarh
c
gudrun
kemmerl
dorothe
muller
r
hen
l
dept
biochemistri
univ
ulm
inst
di
bioi
cellular
del
cnr
roma
itali
larg
antigen
compos
amino
acid
occur
monom
variou
oligom
well
complex
cellular
oncoprotein
detect
distinct
region
polypeptid
chain
larg
antigen
essenti
format
homoand
heterolog
form
analyz
antigen
variou
delet
mutant
found
area
amino
acid
addit
ctermin
region
amino
acid
essenti
oligomer
ctermin
region
amino
acid
nterminu
amino
acid
seem
also
critic
complex
format
analyz
potenti
influenc
phosphoryl
antigen
found
phosphoryl
amino
acid
seem
import
oligomer
complex
format
adenoviru
type
transcript
complex
isol
infect
cell
earli
phase
sediment
analysi
identifi
fast
sediment
complex
type
slow
sediment
complex
type
ii
complex
made
viral
specif
rna
contain
viral
dna
type
ii
type
nucleosom
configur
analysi
protein
complex
antiserum
eiagalactosidas
fusion
protein
express
e
coli
demonstr
follow
type
complex
contain
eia
protein
coprecipit
cellular
protein
mol
wt
b
type
ii
complex
contain
eia
protein
coprecipit
major
cellular
protein
minor
protein
associ
eia
specif
cellular
protein
transcript
complex
sensit
imnaci
dnase
establish
deoxyribonucleoprotein
natur
complex
treatment
transcript
templat
imnaci
dnase
releas
protein
still
remain
strongli
bound
conglomer
cellular
protein
find
indic
specif
antigen
bind
viral
dna
bind
indirect
mediat
cellular
protein
describ
molecular
mechan
persist
adenovirus
ad
organ
still
unknown
therefor
test
human
tonsillar
tissu
infecti
viru
viral
dnasequ
dnadna
hybrid
genom
ad
dna
clone
hind
iii
fragment
herebi
observ
case
infecti
viru
could
neither
isol
directli
ground
tissu
probe
cell
cultur
establish
therefrom
propag
week
month
yet
applic
situ
hybrid
abl
demonstr
adenovir
sequenc
cell
locat
peripheri
cryostat
section
tonsillar
tissu
part
cell
harbor
viral
sequenc
cell
cultur
establish
tonsillar
materi
exhibit
posit
hybrid
signal
portion
cell
southernblot
hybrid
offsiz
band
detect
besid
band
comigr
adenovir
marker
fragment
case
viral
dna
fragment
miss
addit
differ
intens
variou
band
suggest
part
viral
genom
overrepres
herlt
e
gaul
r
neumann
h
j
egger
lnst
f
genetik
univ
bonn
lnst
f
virologi
univ
koln
modern
approach
studi
dnabind
mixtur
protein
consist
fraction
protein
gel
electrophoresi
transfer
nitrocellulos
filter
electroor
diffusionblot
describ
use
nick
translat
biotinlabel
dnaprob
dnabind
studi
phosphorusor
biotinlabel
dnaprob
appli
filter
special
design
vacuumfiltr
apparatu
herebi
becam
possibl
detect
dnabind
activ
even
ng
calf
thymu
core
histon
dot
nitrocellulos
filter
furthermor
chromosom
protein
lower
affin
dna
histon
hi
hmgnonhiston
protein
detect
among
dnanonbind
protein
summari
result
demonstr
dnabind
capac
protein
transfer
nitrocellulos
filter
test
phosphorusa
well
biotinlabel
dnaprob
sensit
label
system
appear
equal
last
year
larg
amount
dna
protein
sequenc
becam
avail
due
rapid
progress
sequenc
techniqu
threedimension
structur
howev
avail
protein
purpos
suffici
obtain
data
secondari
structur
hydrophil
flexibl
surfac
probabl
modif
amino
acid
sequenc
predict
mainli
import
immunolog
question
consequ
applic
howev
may
result
valuabl
inform
threedimension
arrang
protein
paper
present
comput
program
access
sequenc
librari
calcul
secondari
structur
protein
superimpos
predict
addit
valu
creat
twodimension
graph
algorithm
develop
includ
combin
structur
paramet
order
recogn
antigen
site
algorithm
use
predict
epitop
protein
character
xray
cristallographi
lysozym
myoglobin
polioviru
vpl
experiment
well
character
viral
polypeptid
ebv
hlv
fmdv
good
coincid
antigen
profil
could
obtain
program
directli
combin
uwgcg
program
collect
immun
respons
pseudorabi
viru
prv
herp
suid
infect
swine
found
direct
major
glycoprotein
gi
gil
gill
monoclon
antibodi
gil
neutral
pri
vitro
presenc
absenc
complement
individu
mca
also
abl
protect
mice
lethal
challeng
pri
thu
gllcomplex
import
viru
neutral
vitro
vivo
viral
mutant
mar
resist
neutral
individu
antigil
mca
select
one
mutant
resist
neutral
mca
use
select
also
recogn
express
gil
mar
mutant
neither
neutral
mca
use
select
differ
mca
gil
although
gil
express
mar
mutant
activ
genom
pseudorabi
viru
prv
investig
two
latent
infect
pig
week
pi
pryspecif
antigen
could
detect
brain
immunohistochem
stain
thin
section
purpos
polyclon
goat
antiserum
use
recogn
immedi
earli
ie
protein
pri
monoclon
antibodi
specif
major
glycoprotein
gi
gil
gill
major
capsid
protein
pri
react
situ
cytohybrid
strandspecif
probe
crna
synthes
reveal
presenc
pri
iespecif
rna
brain
organ
tissu
anim
pryspecif
dna
sequenc
could
also
detect
southern
blot
hybrid
howev
repres
complet
viral
genom
transfect
permiss
cell
dna
extract
organ
lead
product
pri
structur
gene
glycoprotein
complex
gil
pseudorabi
viru
prv
herp
suid
recent
map
uniqu
long
part
genom
bamhisalifrag
la
ig
mettenleit
et
al
virolog
gllmrna
locat
fragment
ig
southern
blot
analysi
dna
deriv
differ
pri
strain
reveal
heterogen
size
fragment
ig
rang
kbp
subclon
dna
sequenc
differ
ig
fragment
prv
strain
phylaxia
ka
dessau
compar
fragment
analys
exhibit
nearli
ident
dna
sequenc
except
singl
point
mutat
duplic
nucleotid
uniqu
strain
ka
fragment
differ
presenc
variabl
copi
number
direct
repeat
sequenc
nucleotid
variabl
observ
differ
viru
strain
differ
ig
fragment
given
viru
popul
conclud
size
heterogen
fragment
ig
depend
present
copi
number
repeat
unit
final
repeat
unit
seem
locat
code
region
gil
gene
glycoprotein
complex
identifi
pseudorabi
viru
format
gilcomplex
shown
one
precursor
protein
pgil
three
disulfidelink
glycoprotein
complex
gila
gllb
gilc
could
immunoprecipit
monomer
nonreduc
reduc
condit
eg
disulfid
bridgelink
complex
precursor
could
identifi
process
pgil
matur
form
glla
gllb
gilc
protein
identifi
monom
infect
cell
gilcomplex
immunoprecipit
h
pi
electronmicroscop
studi
petri
dish
experi
show
first
envelop
particl
cytoplasm
infect
cell
time
h
pi
format
glycoprotein
complex
indic
nuclear
membran
fraction
play
import
role
format
gilcomplex
viru
infect
porcin
bone
marrow
cell
bm
studi
vitroand
vivoinfect
pseudorabiesviru
prv
pri
infect
shown
viral
multipl
immunofluoresc
electronmicroscop
examin
western
blot
radioimmunoprecipit
pryprotein
well
pryspecif
hybrid
viral
dna
rna
agedepend
decreas
frequenc
pri
replic
bm
b
shown
infecti
center
assay
pryinfect
cultur
bm
pig
less
week
month
b
age
ifstudi
detect
nearli
constant
ratio
bm
posit
immedi
earli
earli
late
viral
protein
prymajor
capsid
proteinposit
bm
pri
isol
bm
experiment
infect
pig
dpi
max
pri
replic
bm
viral
rna
detect
dpi
thu
infect
bm
pri
shwon
establish
infect
cn
pryinfect
bm
corrobor
studi
natur
infect
pig
human
polyomaviru
j
c
persist
system
organ
without
cell
damag
caus
rare
case
progress
multifocalleucoencephalopathi
pml
diseas
associ
lytic
lev
infect
cn
sinc
highli
variabl
lytic
lev
genom
known
contain
celltyp
specif
enhancerpromot
element
ask
whether
lcv
genom
clone
kidney
brain
one
pml
case
viru
isol
ident
sequenc
structur
protein
code
sequenc
genom
ident
shown
sequenc
analysi
control
region
reveal
correspond
base
sequenc
structur
element
core
origin
replic
put
enhancerpromotor
element
howev
show
complex
pattern
insert
structur
chang
suggest
celltyp
specif
rearrang
transcript
control
element
kb
bamhi
hindiii
genom
fragment
low
virul
adv
pullman
high
virul
utah
strain
cell
cultureadapt
lymphotrop
isol
apathogen
advg
variant
clone
adv
pullman
utah
dna
deriv
virion
isol
infect
mink
wherea
adv
rf
dna
latter
strain
origin
cell
cultur
induct
lac
operondepend
protein
express
capsidspecif
antigen
detect
recombin
express
protein
adv
utah
pullman
mw
kd
correspond
protein
advg
kd
smaller
show
addit
loss
kd
result
discuss
emphasi
pathogen
persist
adv
growth
adv
felin
kidney
cell
character
reduc
product
infecti
viru
consecut
passag
adv
viru
titer
drop
detect
limit
fluoresc
focu
assay
ffuml
product
viral
antigen
viral
rna
well
replic
viral
replic
form
dna
found
defect
howev
synthesi
viral
progeni
dna
diminish
h
pi
threefold
less
progeni
dna
synthes
compar
reduct
synthesi
new
viral
dna
strand
may
account
reduc
product
infecti
viru
order
clarifi
prognost
signific
demonstr
hpv
sequenc
cell
taken
cervic
swab
ultim
develop
cervic
cancer
routin
taken
swab
screen
hpv
nuclei
acid
sequenc
use
phosphoru
well
biotinlabel
hpv
dnaprob
far
cell
patient
test
group
exhibit
posit
hybrid
result
neg
result
patient
equivoc
posit
hybrid
signal
regist
group
papanicola
rate
system
group
non
patholog
smear
exhibit
posit
hybrid
result
take
followup
swab
confirm
first
hybrid
result
case
correl
histolog
hybrid
data
detect
posit
signal
squamou
cell
carcinoma
adenocarcinoma
case
rate
carcinoma
situ
specimen
analyz
one
five
dysplasia
also
posit
detect
viral
sequenc
specimen
without
histolog
indic
malign
fuchsl
p
g
f
girardi
engelhardt
h
pfister
inst
f
klin
virologi
univ
erlangen
ceburtshilflichgynakologisch
univklinik
graz
colposcop
direct
cervic
punch
biopsi
austrian
patient
screen
southern
blot
hybrid
presenc
human
papillomaviru
hpv
dna
biopsi
repres
differ
stage
cervic
intraepitheli
neoplasia
cin
invas
carcinoma
well
sampl
histolog
normal
cervic
epithelium
hpv
dna
detect
tumor
biopsi
healthi
epithelium
respect
frequent
hpv
type
test
biopsi
hpv
follow
hpv
andlor
hpv
hpv
sequenc
identifi
invas
carcinoma
hpv
prevail
especi
biopsi
invas
carcinoma
cin
ii
cin
iii
interestingli
hpv
dna
also
detect
histolog
normal
epithelia
hpv
andlor
domin
sampl
mild
dysplasia
hpvposit
biopsi
mix
infect
detect
incid
hpv
andlor
cin
hpv
cervic
cancer
compar
data
contin
indic
possibl
consider
geograph
fluctuat
scholz
j
h
reisner
j
bdgert
g
darai
inst
f
med
virologi
univ
virion
molluscum
contagiosum
viru
mcv
member
poxvirida
isol
directli
lesion
individu
patient
two
countri
germani
hongkong
character
restrict
enzym
analysi
compar
analysi
dna
cleavag
pattern
independ
isol
viru
sampl
reveal
mcv
isol
classifi
two
differ
type
major
mcv
isol
clinic
typic
skin
lesion
show
similar
dna
cleavag
pattern
term
mcv
type
wherea
one
isol
deriv
vagin
lesion
show
complet
differ
dna
cleavag
pattern
therefor
term
mcv
type
confirm
result
dna
mcv
type
separ
label
crosshybrid
southern
blot
hybrid
method
nonradioact
dna
mcv
type
studi
reveal
viral
dna
hybrid
indic
close
relationship
investig
defin
gene
librari
mcv
dna
sequenc
establish
bamhi
dna
fragment
viral
genom
mcv
type
prototyp
isol
mcv
type
insert
bacteri
plasmid
vector
clone
bamhi
dna
fragment
individu
identifi
digest
recombin
plasmid
dna
differ
restrict
enzym
screen
hybrid
recombin
plasmid
dna
viral
dna
use
defin
gene
librari
related
dna
sequenc
mcv
genom
genom
member
poxviru
famili
investigt
detail
studi
progress
studi
support
grant
forderverein
zur
bekampfung
der
viruskrankheiten
ev
sagner
g
g
steger
h
pfister
inst
f
klin
virologi
human
papillomavirus
hpv
induc
benign
skin
tumor
patient
epidermodysplasia
verruciformi
ev
e
v
associ
skin
carcinoma
contain
dna
although
viral
dna
shown
persist
extrachromosom
high
copi
number
viral
protein
could
identifi
rais
antisera
protein
clone
dnafrag
open
read
frame
orf
procaryot
express
vector
result
fusion
protein
immun
rabbit
guinea
pig
sera
use
test
protein
extract
evwart
plantar
wart
immunoblot
assay
antil
serum
recogn
protein
evles
molecular
weight
correl
size
expect
llproduct
earli
protein
could
detect
far
use
chloramphenicol
acetyl
transferas
cat
system
subgenom
fragment
hpv
dna
test
enhanc
activ
activ
could
demonstr
neither
mous
fibroblast
cell
human
epitheli
cell
hela
transform
cell
howev
bp
ecoripvuiifrag
cover
noncod
region
led
clear
increas
cat
gene
express
fragment
activ
independ
orient
upstream
downstream
cat
gene
cotransfect
experi
use
express
vector
differ
gene
well
transfect
experi
cell
transform
delet
mutant
suggest
gene
product
tran
activ
effect
hpv
enhanc
qualit
quantit
differ
note
hpv
specif
transcript
transform
cell
indic
influenc
authent
hpv
transcript
kohler
e
j
kuhn
k
munk
r
braun
inst
f
virusforschung
deutsch
krebsforschungszentrum
crosshybrid
experi
reveal
hybrid
clone
herp
simplex
viru
type
joint
region
kb
hind
iii
fragment
human
embryon
lung
cell
hel
dna
persist
stringent
condit
cellular
fragment
rescu
alibrari
subclon
region
homolog
viral
dna
first
local
bp
sst
ii
subfrag
subclon
bp
subfrag
bgl
hpa
ii
restrict
site
fragment
togeth
adjac
region
sequenc
maxamgilbert
method
sequenc
analysi
reveal
gccontent
open
read
frame
bp
four
stemloop
structur
bp
region
could
determin
repres
homolog
ls
invers
region
sequenc
intens
crosshybrid
viral
joint
region
observ
within
bam
hig
fragment
bp
sst
ii
subfrag
nucleotid
sequenc
fragment
analyz
gccontent
total
futhermor
stemloop
structur
x
directli
repeat
sequenc
nucleotid
detect
bp
dnasequ
correspond
ls
invers
region
show
highest
homolog
cellular
dna
mutat
bovin
papillomaviru
open
read
frame
affect
persist
viral
dna
dietrichgotz
w
h
pfister
inst
f
klin
virologi
univ
analys
function
overlap
open
read
frame
mutagenesi
xbai
linker
carri
tag
termin
codon
mutat
ncoi
end
kpni
follow
featur
cell
transfect
assay
reduc
focu
form
activ
integr
viral
dna
stabil
transform
phenotyp
embryon
mous
fibroblast
immortalis
mutant
could
grown
soft
agar
mutat
near
end
tthllli
contrari
effect
focu
form
activ
wild
type
extrachromosom
persist
mutant
dna
vari
partial
high
copi
number
instabl
transform
phenotyp
correl
loss
viral
dna
asynchroni
viral
cellular
dna
replic
could
observ
assum
play
role
long
term
mainten
extrachromosom
persist
viral
dna
molecul
molecular
clone
character
novel
papillomaviru
type
patient
hodgkin
diseas
elling
l
k
g
fuch
l
g
gross
h
pfister
l
inst
f
klin
virologi
univ
erlangen
univhautklinik
freiburg
patient
hodgkin
diseas
develop
macular
skin
lesion
year
treatment
xray
chemotherapi
dna
extract
lesion
kb
papillomaviru
genom
clone
vector
pic
partial
hind
iii
digest
seen
southern
blot
analysi
isol
show
homolog
human
papillomaviru
hpv
lesser
extent
sever
virus
occur
skin
lesion
patient
epidermodysplasia
verruciformi
ev
pattern
dna
homolog
clone
hpv
hpv
type
differ
hpv
extent
crosshybrid
hpv
measur
reassozi
liquid
phase
virus
differ
physic
map
restrict
enzym
cleavag
site
data
infer
clone
dna
repres
new
hpv
type
belong
group
evvirus
krau
j
th
iftner
h
pfister
inst
f
klin
virologi
univ
human
papillomavirus
hpv
belong
group
epidermodysplasia
verruciformi
ev
associ
hpv
contrast
hpv
hpv
detect
skin
carcinoma
patient
sequenc
rr
hpv
sequenc
analysi
hpv
reveal
strong
continu
homolog
hpv
wherea
hpv
show
insert
rearrang
six
sequenc
motif
share
ev
specif
hpv
palindrom
accgnnnncggt
found
within
rr
pv
occur
time
within
ev
specif
rr
play
role
bind
site
protein
act
control
element
transcript
u
schiller
per
comm
intermingl
palindrom
found
late
promoterlik
sequenc
uniqu
featur
hpv
block
altern
residu
end
rr
foami
virus
spumavirina
subfamili
retrovirida
caus
persist
infect
variou
mammalian
speci
probabl
includ
man
sfv
strain
isol
african
green
monkey
reveal
tlymphotrop
properti
variou
infect
cell
provir
dna
detect
hybrid
viral
cdna
probe
prepar
vitro
revers
transcript
j
gen
virol
character
non
integr
linear
doublestrand
dna
kb
contain
gap
sensit
nucleas
probabl
two
whole
genom
link
singlestrand
dna
form
tandem
structur
describ
visnalentiviru
provir
dna
infect
molta
cell
cleav
xhoi
clone
lambda
posit
plaqu
identifi
hybrid
viral
cdna
kb
insert
isol
subclon
puc
viral
insert
dna
probe
strong
hybrid
occur
dna
cell
infect
wherea
sfv
prototyp
human
syncytium
form
viru
show
weak
hybrid
signal
less
stringent
condit
support
deutsch
forschungsgemeinschaft
ne
htlvliib
siv
studi
iem
surfac
replica
thin
section
em
morphogenesi
viru
core
compon
assembl
concomit
bud
cell
surfac
spheric
rnpcore
complex
nm
thick
appos
viru
envelop
matur
complex
rearrang
tubular
core
shell
antigen
rnpnucleoid
inner
side
envelop
membran
protein
locat
immatur
hiv
dens
stud
probabl
surfac
knob
nm
diamet
viral
envelop
determin
reveal
sera
hiv
infect
person
show
close
qualit
correl
label
densiti
envelop
neutral
capac
viru
matur
knob
lost
progress
shed
discuss
possibl
pathomechan
three
peptid
correspond
residu
lav
htlviii
envelop
glycoprotein
precursor
synthes
criteria
select
peptid
conserv
amino
acid
residu
hydropath
charact
region
sera
aidspati
lavlhtlviii
posit
person
normal
donor
test
presenc
antibodi
recogn
posit
sera
show
reactiv
peptid
peptid
peptid
peptid
recogn
sera
control
group
limit
detect
peptid
recognit
posit
sera
characterist
serum
dilut
yet
real
anim
model
aid
cours
studi
ofstlvi
variou
primat
speci
observ
anim
notabl
among
african
green
monkey
baboon
also
possess
antibodi
react
hiv
elisa
western
blot
african
green
monkey
cercopithecu
aethiop
rais
close
coloni
paul
ehrlichinstitut
seroposit
hiv
obvious
healthi
virus
isol
anim
stlviii
agm
shown
cytopathogen
cultur
tlymphocyt
human
macaqu
origin
thu
far
howev
isol
replic
low
titer
vitro
effort
character
stlviii
agm
protein
dna
vivo
inocul
stlviii
agm
human
immunodefici
virus
hiv
obtain
aidsor
la
patient
show
differ
cytopath
effect
cpe
induc
fresh
peripher
lymphocyt
two
cytopath
isol
german
patient
use
studi
compar
case
infect
virusproduct
cytopath
effect
differ
line
tlymphocyt
molt
cem
hut
hl
freshli
prepar
cord
lymphocyt
well
cord
lymphocyt
immort
stlv
uninfect
cell
line
produc
spontan
syncytia
consequ
product
cytopath
effect
virus
difficult
judg
base
morpholog
cell
alon
cellvit
therefor
determin
use
fluoresc
techniqu
allow
readili
distinguish
live
dead
cell
establish
cell
line
prove
much
resist
infect
viru
strain
freshli
prepar
cord
lymphocyt
even
cell
line
similar
origin
signific
differ
infect
well
viru
product
observ
experi
demonstr
product
hiv
strongli
depend
cellular
event
schneider
j
wendler
l
ha
yami
r
desrosi
g
hunsmann
l
deutsch
primatenzentrum
institut
med
scienc
tokyo
japan
new
england
region
primat
research
center
southborough
mass
usa
simian
immunodefici
virus
siv
relev
understand
origin
human
immunodefici
viru
hiv
establish
anim
model
human
aid
examin
sera
nonhuman
primat
speci
antibodi
hiv
siv
combin
elisa
radioimmunoprecipit
rip
sera
green
monkey
three
close
relat
speci
frequent
posit
assay
siv
isol
green
monkey
sooti
mangabey
rhesu
monkey
classifi
compar
hiv
crossreact
respect
antisera
rip
assay
respect
peripher
envelop
glycoprotein
simian
virus
repres
subgroup
differ
hiv
sinc
simian
sera
react
homolog
heterolog
glycoprotein
siv
isol
hiv
core
polypeptid
bidirect
crossreact
four
virus
except
sera
green
monkey
lack
antibodi
core
polypeptid
howev
isol
distinquish
tryptic
peptid
map
core
polypeptid
see
abstract
jurkiewicz
et
al
human
immunodefici
virus
hiv
lav
htlv
iii
arv
aav
cultur
either
peripher
blood
lymphocyt
pbl
plasma
whole
blood
cerebrospin
fluid
csf
aid
arcand
asymptomat
patient
mainli
frankfurt
isol
shown
lavhtlv
iiirel
revers
transcriptas
test
crossreact
immunofluoresc
assay
electron
microscopi
southern
blot
analysi
probe
htlv
iiispecif
probe
lambda
hiv
isol
grown
fresh
human
pbl
strike
differ
morpholog
cytopath
effect
induc
pbl
found
among
also
reflect
viru
titr
speed
growth
immunofluoresc
assay
hiv
isol
show
differ
sensit
detect
virusantibodi
patient
sera
restrict
analysi
molecularyli
clone
isol
reveal
differ
publish
restrict
pattern
clone
hiv
multipl
variant
within
given
patient
observ
variat
isol
confin
area
argu
high
mutat
rate
hiy
question
rais
whether
differ
clinic
cours
infect
hiv
correl
particular
subtyp
furthermor
develop
effect
vaccin
hiv
depend
avail
character
wide
spectrum
variant
studi
show
epitop
individu
mutant
import
neutral
antibodi
independ
isol
human
immunodefici
viru
hiv
exhibit
strike
genom
divers
locat
viral
envelop
gene
sinc
properti
hiv
group
virus
may
play
import
role
pathobiolog
hiv
analyz
amino
acid
sequenc
envelop
protein
eleven
differ
viral
strain
three
repres
sequenti
isol
singl
patient
use
comput
program
predict
secondari
protein
structur
superimpos
valu
hydrophil
surfac
probabl
flexibl
identifi
sever
potenti
antigen
site
envelop
protein
hiv
interestingli
major
predict
epitop
exterior
envelop
protein
found
region
high
sequenc
variabl
among
independ
also
sequenti
viral
isol
interspread
highli
conserv
region
membraneassoci
polypeptid
contain
highli
variabl
region
amino
acid
found
conserv
two
antigen
site
could
identifi
find
give
insight
secondari
possibl
tertiari
structur
variant
hiv
envelop
protein
facilit
experiment
approach
direct
toward
identifi
fine
map
hiv
envelop
protein
revers
transcriptas
rna
depend
dna
polymeras
rddp
isol
densiti
gradient
band
human
immunodefici
viru
hiv
four
chromatograph
step
enzymat
templat
primer
ion
requir
kinet
paramet
micha
constant
hill
coefici
sever
substrat
determin
order
find
inhibitor
specif
hiv
rddp
effect
hiv
rddp
partial
purifi
cellular
dna
polymeras
larg
number
drug
test
compar
inhibitori
dosi
id
concentr
drug
enzymat
activ
inhibit
known
rddp
inhibitor
equal
even
activ
cellular
polymeras
contrast
tetracyclin
exhibit
rel
specif
effect
hiv
rddp
howev
therapeut
applic
substanc
found
show
specif
inhibitori
effect
hiv
rddp
nearli
effect
cellular
polymeras
substanc
test
phosphonoform
acid
deriv
examin
collabor
astra
sweden
fulfil
requir
borna
diseas
viru
bdv
regard
recent
strictli
neurotrop
agent
propag
along
neur
al
path
way
develop
mon
oclon
antibodi
viral
antigen
highli
sensit
immunohistochem
techniqu
allow
assess
exact
distribut
viral
antigen
neural
nonneur
tissu
nervou
system
ns
viru
specif
antigen
could
demonstr
besid
neuron
astrocyt
oligodendrogli
cell
ependyma
choroid
plexu
epithelium
pigment
epithelium
eye
periph
al
ns
axon
invari
posit
schwann
cell
prove
consequ
non
permiss
bdv
among
nonneur
tissu
lacrim
sebac
salivari
gland
smooth
muscl
cell
epidermi
pituitari
adren
gland
brown
fat
permiss
bdvinfect
liver
kidney
lung
skelet
muscl
elect
vulnerabil
iti
tissu
cell
type
specif
distribut
surfac
receptor
may
offer
plausibl
explan
l
g
gosztonyi
h
ludwig
inst
f
neuropathologi
und
inst
f
virologi
freie
univ
berlin
borna
diseas
slow
viru
infect
distribut
viru
mostli
restr
ict
nervou
system
neuron
glial
cell
follow
ocular
inocul
rat
borna
diseas
viru
brain
infect
ensu
centripet
spread
agent
mainli
along
optic
nerv
borna
specif
ant
igen
determin
immunohistochem
first
day
nuclei
neuron
central
nervou
system
despit
unilater
inocul
immunoreact
cell
app
ar
local
symmetrical
diencephalon
brain
stem
phase
follow
rapid
spread
borna
diseas
viru
whole
brain
besid
axon
transsynapt
mechan
oligodendrocyt
probabl
also
involv
propag
infect
prote
deposit
host
encod
prop
erti
amyloid
found
brain
scrapi
infect
hamster
socal
scrapieassociatedfibril
saf
absent
scrapiespleen
comp
are
brain
mat
erial
similar
scrapi
titer
sv
delay
approxim
day
format
safprotein
intraperiton
infect
hamster
follow
dramat
increas
scrapi
titer
plateau
brain
clinic
sign
start
consider
amount
saf
accumul
accord
observ
infect
scrapi
lead
lethal
organ
specif
amyloidosi
borna
diseas
bd
viru
infect
lead
either
fatal
encephalomyelitid
hors
rabbit
adult
rat
lifelong
persist
without
diseas
iday
old
mous
rat
chicken
independ
diseas
toler
infect
bd
viru
infect
anim
react
strong
humor
immun
respons
first
promin
answer
direct
complex
virusinduc
protein
solubl
antigen
sag
sag
enrich
supernat
prepar
infect
brain
sonic
ultracentrifug
x
g
immunogen
sag
compon
character
westernblotanalys
found
l
antigen
complex
consist
two
major
protein
appar
molecular
weight
kd
protein
recogn
polyclon
seruma
well
oligoclon
csfantibodi
test
speci
rabbit
hors
mous
rat
rhesu
monkey
monoclon
antibodi
equal
well
react
epitop
sag
protein
two
three
monoclon
antibodi
bind
kd
protein
reactiv
pattern
sag
compon
could
correl
presenc
absenc
neutral
capac
antibodi
report
immunolog
relationship
human
pdfg
ssv
transformationspecif
glycopeptid
ssvtrsgp
virolog
ssvtrsgp
repres
proteoglycanlik
molecul
releas
ssvtransform
cell
regard
put
biolog
activ
molecul
found
nonfraction
cell
serum
viru
free
tissu
cultur
supernat
show
growthstimul
activ
pdgflike
characterist
nih
cell
furthermor
tissu
cultur
supernat
induc
anchorageindepend
growth
nrk
cell
caus
dramat
morpholog
alter
variou
cell
line
nonestablish
fibroblast
evid
ssvtrsgp
involv
process
come
two
addit
find
fraction
supernat
ssvnp
cell
gel
filtrat
major
growthstimul
transform
activ
present
void
volum
kd
use
supernat
prepar
sdspage
highmolecularweight
kd
growthstimul
activ
electroelut
ibdv
spi
u
h
muller
h
becht
lnst
virolog
univ
gieben
ibdv
member
famili
birnavirida
nake
icosahedr
viru
particl
singleshel
compos
sever
polypeptid
contain
two
segment
doublestrand
ds
rna
mol
wt
x
x
rna
depend
rna
polymeras
activ
associ
infecti
ibdv
particl
induc
enzym
activ
essenti
remov
ca
h
ion
howev
mg
h
ion
present
superior
mn
h
enzym
activ
enhanc
nonion
deterg
ph
dc
reaction
linear
time
least
one
hour
reach
plateau
h
later
final
ceas
h
reaction
product
dsrna
virion
rna
singlestrand
rna
hybrid
genom
segment
view
natur
product
ibdv
polymeras
act
transcriptas
well
replicas
muller
h
r
nitschk
inst
f
virologi
justusliebiguniv
gieben
bundesamt
f
sera
u
impfstoff
paul
ehrlichinst
frankfurt
two
doublestrand
ds
rna
segment
ibdv
releas
viru
particl
treatment
proteinas
k
presenc
sd
investig
electron
microscop
linear
dsrna
molecul
observ
length
compar
complet
sequenc
reoviru
type
segment
mol
wtsof
x
x
calcul
result
indic
genom
member
famili
birnavirida
also
smaller
report
seen
electron
microscop
heat
ibdv
particl
presenc
sd
without
proteinas
k
result
dsrna
molecul
circular
protein
electrophoresi
radioact
label
particl
differ
gel
system
indic
protein
structur
protein
ibdv
suppos
repres
part
rna
depend
rna
polymeras
aedesalbopictuc
cell
infect
sfv
induc
fuse
within
ph
appli
hydrophil
reagent
coval
modifi
protein
cell
surfac
reagent
appli
ph
cultur
ph
lower
cultur
cell
expos
ph
c
sever
chemic
react
amino
guanidino
sulfideand
disulfid
group
inhibit
fusion
appli
low
ph
exposur
basi
result
implic
low
ph
induc
conform
chang
protein
radioact
reagent
util
sfv
envelop
protein
could
identifi
protein
undergo
conform
chang
genom
insect
iridesc
viru
type
chilo
iridesc
viru
civ
shown
circularli
permut
termin
redund
upon
denatur
reanneal
nativ
linear
civ
dna
kbp
duplex
dna
circl
smaller
size
kbp
protrud
tail
form
defin
complet
gene
librari
whole
civ
dna
sequenc
establish
use
insert
ecori
dna
fragment
e
l
correspond
site
plasmid
vector
furthermor
civ
dna
cleav
restrict
endonucleas
bamhi
ncol
sail
sphl
andor
doubl
digest
bamhisal
result
dna
fragment
insert
bamhi
bamhisal
sphl
site
bacteri
plasmid
vector
ncoi
site
plasmid
vector
clone
fragment
individu
identifi
hybrid
experi
physic
map
viral
dna
construct
restrict
endonucleas
apal
smal
bamhi
sall
ncol
although
civ
genom
linear
due
circular
permut
restrict
map
ciruclar
defin
complet
gene
librari
clv
dna
use
structur
function
analys
genom
interest
virusthi
studi
support
deutsch
forschungsgemeinschaft
project
da
human
parvoviru
caus
agent
erythema
infectiosum
viraemia
viral
dna
detect
dna
hybridis
kb
dna
fragment
parvoviru
genom
clone
pgem
use
radioact
probe
techniqu
parvoviru
posit
blood
probe
could
detect
serv
antigen
sourc
establish
igmigg
antigen
captur
assay
flatbottom
mirotit
plate
coat
antiv
resp
antia
incub
test
sera
antigen
monoclon
antiparvoviru
antibodi
incub
peroxidaseconjug
antimous
igg
orthophenylendiamin
perhydrol
ad
enzymat
reaction
stop
h
optic
densiti
measur
detect
viral
antigen
strongli
antiparvo
posit
serum
coat
test
serum
ad
procedur
perform
describ
compar
antigen
elisa
dnahybridis
dnahybridis
fold
higher
sensit
pgml
dna
could
detect
detect
specif
enabl
serolog
diagnosi
acut
past
parvoviru
infect
blood
donat
screen
antigen
captur
assay
use
fmdi
strain
ojk
neutral
monoclon
antibodi
nmab
four
differ
specif
isol
nmab
first
character
regard
neutral
pattern
two
nmab
show
quit
narrow
differ
neutral
pattern
contrast
third
nmab
react
test
serotyp
c
crossneutr
certain
c
subtyp
observ
fourth
nmab
latter
two
nmab
react
ypi
western
blot
elisawitha
synthet
peptid
whose
sequenc
aa
ypi
ojk
shown
import
induct
neutral
antibodi
respect
experi
two
narrow
react
nmab
neg
thu
two
nmab
may
recogn
continu
sequenc
defin
region
vpl
hypothesi
test
directli
sinc
neutral
resist
variant
isol
preliminari
respect
nucleic
acid
sequenc
data
present
analysi
induc
suppress
humor
antibodi
format
bcell
enumer
nick
b
metzger
muller
falk
div
expo
virolog
insr
med
microbiolog
johannesgutenberguniv
maim
hsyl
induc
suppress
humor
antibodi
format
well
srbc
hbsantigen
pinject
silica
partial
releas
suppress
therefor
first
target
j
gen
virol
order
analys
exactli
mechan
suppress
determin
number
hsyspecif
igmor
igg
produc
bcell
primari
homolog
heterolog
secondari
infect
high
low
dosi
hsyl
induc
phase
nonreact
spleen
day
high
dose
secondari
infect
hsyl
day
manifest
antibodi
secret
bcell
spleen
humor
antibodi
respons
howev
regular
day
typic
bcell
iggboost
respons
manifest
spleen
induc
suppress
wane
day
pi
indic
antigen
present
memori
cell
stabl
switch
igm
igg
product
seem
damag
confirm
analysi
hsyspecif
low
bcell
respons
specif
bcell
appear
late
compar
hsyl
suppressor
tcell
also
seem
produ
suppress
demonstr
day
infect
gener
induc
low
total
spleen
cell
respons
compar
hsyl
w
b
walter
g
klotz
dept
virolog
univ
ulm
polyhedr
viru
diamet
nm
viral
genom
linear
doublestrand
dna
mol
wt
infect
nonlyt
cytocid
circular
permut
termin
redund
shown
three
differ
method
restrict
pattern
dna
show
nearli
constant
decreas
mol
wt
fragment
differ
equal
total
genom
size
indic
shift
permut
determin
eco
ri
bind
site
dna
electron
microscopi
reveal
three
popul
molecul
end
one
class
shift
urn
ie
genom
size
treatment
exonucleas
iii
gener
protrud
singlestrand
end
follow
renatur
show
homolog
termin
region
homolog
extend
genom
length
maueler
w
f
raulf
schartl
maxplanckinst
biochemistri
gene
center
martinsri
genom
xiphophoru
contain
sever
protooncogen
homolog
transform
gene
certain
retrovirus
specif
cross
differ
genotyp
xiphophoru
lead
spontan
format
benign
malign
melanoma
offspr
order
obtain
better
understand
function
protooncogen
oncogen
nontransform
neoplast
transform
cell
respect
studi
express
csrc
era
csi
cerba
cerbb
cmycdur
embryogenesi
adult
tissu
melanoma
xiphophoru
embryogenesi
csrc
era
csi
differenti
express
adult
era
cmycar
tissuespecif
express
show
overexpress
melanoma
csrc
also
express
tissuespecif
highest
level
found
melanoma
high
level
cerbb
csi
relat
mrna
detect
melanoma
cell
data
indic
normal
function
protooncogen
differenti
prolifer
coordin
deregul
sever
oncogen
melanoma
format
novemb
seal
got
infest
thin
section
bioptic
skin
specimen
poxviru
inclus
bodi
type
b
found
neg
stain
tritur
suspens
bioptic
specimen
typic
parapoxviru
particl
detect
far
attempt
fail
propag
viru
embryon
cell
sheep
skin
kidney
inquiri
three
rear
station
along
north
sea
coast
reveal
similar
skin
alter
seen
least
two
place
name
norden
summer
pieterburenlnetherland
character
poxviru
isol
child
rosen
l
j
pilaski
g
darai
l
inst
f
med
virologi
univ
heidelberg
med
institut
f
umwelthygien
univ
dusseldorf
girl
liineburgilow
saxoni
vaccin
smallpox
develop
skin
lesion
central
necrosi
left
hand
april
orthopoxviru
strain
isol
nasemann
et
al
sinc
strain
produc
effloresc
mm
diamet
haemorrhag
center
chorioallanto
membran
cytoplasm
inclus
bodi
type
v
incorpor
group
cowpoxlik
virus
term
hcplsax
dna
restrict
pattern
viru
strain
compar
orthopoxvirus
use
endonucleas
bamh
hind
iii
sma
sac
kpn
sma
hind
iii
fragment
pattern
isol
hcplsax
nearli
ident
cowpoxlik
viru
strain
ep
isol
asian
eleph
elepha
maximu
zoolog
garden
frankfurt
novemb
girl
contact
zoo
anim
live
close
contact
pet
anim
like
cat
rabbit
dog
guinea
pig
determin
viral
glycoprotein
antigen
elisa
invitro
assay
potenc
rabi
vaccin
thraenhart
c
ramakrsihna
centr
f
refer
research
neurol
zoonos
inst
med
virolog
immunolog
univ
essen
content
rabi
viru
glycoprotein
antigen
glpag
correl
immunogen
tissu
cultur
vaccin
rabi
elisa
base
determin
glpag
monospecif
polyclon
antiglpantibodi
direct
rabi
viru
strain
era
fluri
lep
pv
therefor
may
replac
invivo
protect
test
mous
nihtest
elisa
standard
base
fixat
differ
vaccin
dilut
start
solid
phase
microtitr
plate
reaction
excess
anti
glpantiserum
h
follow
incub
peroxidas
coupl
antiigg
hat
measur
reaction
nm
minut
addit
substrat
condit
abl
determin
potenc
tissu
cultur
rabi
vaccin
differ
viru
strain
characterist
procedur
product
tissu
cultur
supernat
vaccin
concentr
vaccin
heat
treatment
adsorpt
al
ohh
glpag
unknown
sampl
test
parallel
refer
vaccin
known
potenc
quantit
parallel
line
bioassay
accord
finney
statist
method
biolog
assay
ch
griffin
comp
london
high
wycomb
elisa
result
correl
result
obtain
nihtest
rang
iv
glpag
express
bhkcell
h
increas
maximum
h
infect
thermost
lyophil
vaccin
demonstr
pcecand
verovaccin
c
day
h
howev
vaccin
store
liquid
form
potenc
decreas
rapidli
less
h
c
stabil
glpag
dc
seem
influenc
stabil
vaccin
first
result
show
stabl
glpantigen
resuspend
pcec
vaccin
day
c
decreas
glpantigen
resuspend
vero
vaccin
day
storag
c
tropic
therefor
prefer
lyophil
vaccin
human
monoclon
antibodi
humab
direct
viral
antigen
develop
combin
immort
human
primari
b
lymphocyt
epsteinbarr
viru
ebv
infect
consecut
fusion
select
immort
lymphoblast
establish
human
lymphoblastoid
cell
line
among
antivir
humab
produc
hybridoma
thu
gener
three
produc
antirubella
humab
rubella
viru
consist
three
structur
protein
core
protein
c
two
envelop
protein
el
western
blot
techniqu
abl
show
two
humab
react
core
protein
third
humab
envelop
protein
el
hybridoma
grown
stationari
cultur
highli
purifi
humab
prepar
obtain
subject
concentr
cultur
supernat
immunoaffin
chromatographi
winter
j
h
wege
r
watanab
v
ter
meulen
inst
f
virologi
u
immunbiologi
univ
wlirzburg
coronaviru
jhm
infect
rodent
lead
diseas
central
nervou
system
accompani
demyelin
model
import
studi
pathogenesi
outcom
infect
depend
properti
viru
virul
avirulentjhmvirus
differenti
peplom
protein
function
attach
bind
neutralis
antibodi
fusion
learn
relat
structur
virul
use
monoclon
antibodi
mab
select
jhmvariant
chang
defind
infect
hybridoma
line
produc
neutralis
mab
lead
select
jhmvariant
escap
neutralis
antigen
structur
chang
detect
four
differ
group
jhmvariant
select
correspond
epitop
associ
neutralis
cell
fusion
mice
infect
variant
chang
epitop
develop
predominantli
chronic
diseas
jhmvariant
chang
one
major
epitop
caus
acut
diseas
like
jhmwild
type
viru
data
indic
virul
associ
defin
domain
peplom
protein
main
replicas
higher
eukaryot
cell
dna
polymeras
contain
tightli
associ
dna
primas
demonstr
enzym
abl
initi
dna
replic
invitro
multipl
site
clone
singlestrand
dna
singlestrand
parvovir
dna
contrast
use
natur
occur
singlestrand
ciruclar
porcin
circoviru
pcv
dna
investig
initi
dna
replic
purifi
dna
polymeras
aholoenzym
calf
thymu
prime
specif
one
prefer
site
eukaryot
cell
natur
coccur
singlestrand
dna
templat
structur
characterist
budgerigar
fledgl
diseas
bfdv
analyz
biochem
biophys
method
result
obtain
justifi
classif
bfdv
member
polyomavirus
papovaviru
subgroup
bfdv
relat
member
subgroup
ident
anyon
therefor
new
first
nonmammalian
polyomaviru
viru
abl
transform
hamster
embryo
cell
vitro
typic
featur
polyomavirus
howev
polyomavirus
known
caus
persist
infect
without
clinic
symptom
natur
host
bfdv
etiolog
agent
acut
diseas
result
high
death
rate
affect
bird
